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(…) water will one day be employed as a fuel, that hydrogen and oxygen that constitute it, used singly or together, will furnish an inexhaustible 
source of heat and light, of an intensity of which coal is not capable. Someday the coal rooms of steamers and the tenders of locomotives will, 
instead of coal, be stored with these two condensed gases, which will burn in the furnaces with enormous caloric power (…). I believe, that 
when the deposits of coal are exhausted, we shall heat and warm ourselves with water. (…) Water will be the coal of the future (…). 
 
 
Jules Verne (1828 – 1905), “L’Ile Mystérieuse”1874 
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It is estimated that the world’s population will reach 11 billion by 2100 and thus the energy 
need will increase. Already today this is a delicate topic since the use of finite energy sources as coal 
and oil are depleting. Furthermore, the CO2 released is negatively effecting the climate.  
Artificial photosynthesis to produce hydrogen as a clean fuel is one possibility that caught 
much attention. The reaction product of hydrogen and oxygen is solely water.  
Many small molecule catalysts have already been reported that produce hydrogen, but they 
are not as active as natural hydrogenases. Natural enzymes have a highly evolved and sophisticated 
coordination sphere around the catalytic center, as well as hydrogen, proton and electron channels. 
These features are hardly added by synthetic modification of a ligand of a small molecule catalyst. 
Incorporation of those catalysts into a protein scaffold would add a second coordination sphere that 
mimics natural enzymes. 
In this context, this thesis explores the biocompatibility of some molecular catalysts that 
produce hydrogen from formic acid for future in vivo or protein incorporation applications. Here, we 
could show that certain complexes show good turnovers and high recyclability rates, as well as oxygen 
tolerance under bio-compatible reaction conditions.  
To address the matter of electron transfer in proteins and their surface we explored the 
electron transfer properties of a dyad of an electron donating triarylamine and a bio-conjugated 
ruthenium photosensitizer. Different distances of the dyad were tested and the best system was further 
improved. Not only was an electron acceptor also bio-conjugated to the proteins N-terminus, but also 
a negative patch of three negatively charged amino acids was introduced in close proximity to the 
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photosensitizer. This negative patch increased the local concentration of the electron acceptor, even 
when not tethered to the protein. We could show that the protein can successively be bio-conjugated 
in three different ways: i) biotin-binding, ii) nucleophilic substitution on a cysteine residue and iii) N-
terminal modification. The compatibility of these biorthogonal bio-conjugation procedures may open 
a new possibility of assembling catalytic systems on a protein surface. 
The thesis further discusses the use of the biotin-streptavidin technology to assemble an 
artificial hydrogenase to perform hydrogen evolution. A small molecule pentapyridin ligated Co 
catalyst was incorporated into different mutants of streptavidin and photocatalytic hydrogen 
evolution was measured. It could be shown that a lysine that was incorporated via mutagenesis has a 
beneficial influence on turnover numbers and rates. We also found that it decreased the initial lag-
phase, often seen in small molecule hydrogen evolution catalysts, significantly. These findings support 
the idea that basic residues in close proximity to a hydrogen reducing or oxidizing catalyst have a 
positive impact, giving insights into its mechanism. The fact that the biotin-streptavidin provides a 
catalyst incorporated into a protein binding pocket also enables to exclude a heterolytic hydrogen 
evolution mechanism often proposed, since the Co-centers are too far away to react with each other, 
at least in our system. 
We envision that these findings will help to develop artificial hydrogenases that are at least as 
active as natural hydrogenases. 
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1 General Introduction 
 
When the industrial revolution started in the late 18th century in Great Britain, mankind was 
not aware of the negative impacts that an improved quality of life might bring for future generations 
150 years later (Figure 1.1).[1,2] There is no doubt that the increase in productivity, efficiency, mobility 
and a secure production of food changed the world as mankind knew it until then. Little was known 
about the consequences that continuous burning of fossil fuels might have on climate. Nowadays, the 
effects of greenhouse gases as CO2 or methane are well understood and tremendous efforts on finding 
a solution to said problems are undertaken by scientists worldwide.[3,4] Their aim is to find sustainable 
and renewable ways to produce carbon-free or carbon neutral energy. 
The world’s energy consumption has increased by a factor of 200 since 1850, with coal, oil and 
gas being by far the most used sources of energy (Figure 1.1). Burning fossil fuels produces CO2 which 
is released into the atmosphere. The rise of the CO2-level can be linked to the growth of the world 
population and its accompanying need for more energy (Figure 1.2). While there are currently about 
7.6 billion people on earth, it is estimated that by 2050, there will be 9 billion inhabitants and by 2100, 
11.2 billion people. This calls for a radical change in energy production habits.[1]  
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Figure 1.1: Rise in energy consumption since the first industrial revolution from 1850 till today. The Figure is reproduced 
from reference[1]. 
 
Not only climate change is a reason to address the energy problem, but also the finite nature 
of our primary source of fuels. The world’s finite resources of natural gas, petroleum, uranium and coal 
sum up to around 1.570 Twy (terawatt-year), which means, that they will only last for another 85 
years, given the annual world energy consumption of 18.5 Twy (Figure 1.3). Yet, it Is expected that 
this number will increase by 2050 to 28 Twy.[5] 
Renewable resources on the other hand offer a different picture. While tidal, geothermal, 
wave, hydro, biomass or OTEC (Ocean Thermal Energy Conversion) only show relatively small 
amounts of potential annual energy, wind energy could easily fuel the whole world if harvested 
accordingly. Solar energy on the other hand is the major energy source we could utilize on our planet. 
Annually, the sun shines 1250 times more energy on earth than we need to sustain worldwide energy 
needs.  
Harvesting that energy is one problem, storing that energy is another.[6] In Winter time, most 
energy is utilized for heating or illumination purposes but since there is less sunshine for example and 
the days are shorter, the energy should to be stored while there is sun or to be transported from areas 
of the world where there is more sunshine duration. 
Transporting energy directly via landlines is a problem, since there is a huge loss because of 
resistance and produced heat. A common way to store energy is by pumping water uphill into a 
reservoir and, when needed, the water runs downhill to produce energy by passing through turbines.[7] 
A drawback is that mountains are not omnipresent, allowing to implement such a system and even if, 
it comes along with a huge amount of construction and cost. Another possibility are batteries: they 
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could be charged at a certain location and transported to a location of interest.[8] A major disadvantage 
is that such batteries are often very heavy and thus their transportation is difficult and energy intensive. 
 
 
Figure 1.2: (a) Exponential growth of the world population from 1750 to 2050 (black squares),[9,10] (b) Exponential 
increase in greenhouse gas emissions from 1750 to 2006 (red trace).[11]  
 
A more economical way to store energy would be using the smallest batteries known to man: 
chemical bonds. The energy produced can be stored between two atoms to form a stable molecule 
and that energy could be released at any desired location when needed. The produced molecule 
should be easily transportable, light and no waste products as CO2 or other greenhouse gases should 
be released upon combustion. 
A molecule that caught much attention that partially fulfills these criteria is molecular 
hydrogen.[12,13] But unlike fossil fuels, hydrogen is not readily available in nature. However, it can be 
produced from many energy sources and be used as a fuel, either for direct combustion or in a fuel cell, 
only producing water as byproduct.[14] Hydrogen possesses the highest energy content compared to 
any known fuel and is globally accepted as an environmentally benign secondary form of renewable 
energy. It can be stored as compressed gas, cryogenic liquid, solid hydride or in hydrogen carriers as 
formic acid for example.[15]  
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Figure 1.3: Totally estimated, recoverable finite (outside the solar circle) and the yearly potential energy of renewable 
(inside the solar circle) planetary energy reserves in Terawatt-years by 2015. The annual potential energy of the sun is 
1250 times higher than the annual energy use of the whole planet. The energy values were transferred into a volume of a 
sphere, yet, the representation is only two-dimensional, so the real difference of the different values is much higher. The 
figure is adapted from reference [5]. 
 
Molecular hydrogen can be produced from fossil fuels by steam reforming, partial oxidation, 
autothermal reforming or hydrocarbon pyrolysis.[16] When renewable sources are used instead, H2 can 
be produced by biomass, thermochemical or biological processes. One more interesting way is water 
splitting either by thermolysis or photo-electrolysis. When the required energy is provided by 
renewable energy sources, the hydrogen produced is the unarguably the cleanest fuel available. 
 Nature uses the sun’s radiant energy in a process called photosynthesis, storing energy in 
chemical bonds.[17] Mimicking that process is one of the biggest challenges of current research and 
accomplishing a so called artificial photosynthesis would be a big leap for mankind to overcome our 
addiction for ever-increasing energy.[18–22] 
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2 Theoretical Background 
2.1 Hydrogen 
2.1.1 What is Hydrogen? 
There are at the moment 118 elements known in chemistry of which over 90 occur naturally. 
Hydrogen is the lightest element and it exists as H2. Dihydrogen consists of two protons and two 
electrons. After its discovery in 1766 by the British chemist and physicist Henry Cavendish, its name 
“hydro-gène” (“water producer”) was first introduced by the French chemist Antoine Laurent de 
Lavoisier in 1787, from the Greek words “hydor” (water) and “genes” (producing).[23] It was the first 
element created in the Universe after the Big Bang and it is the first element in the periodic table.[12] 
After hydrogen was discovered in the 18th century as a flammable gas, important technologies for the 
production and the use of hydrogen were developed in the 19th and early 20th century.[24] Its potential 
for the energy industry was then recognized and it was already early envisioned,[13] that hydrogen 
could play a big role as an energy source in the future, given its very high energy content (120 MJ/kg 
for hydrogen versus 44 MJ/kg for gasoline, Figure 2.1).[25] This is one reason why it has been used as 
a fuel for space travel since the 60s.[26] Hydrogen is a clean and sustainable energy option, because its 
combustion product with oxygen is only pure water[14]. Yet, so far, the energy sources used mostly still 
rely on fossil fuels.  
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Figure 2.1: Comparison of the volumetric versus gravimetric energy density of a group of materials and technologies. 
Hydrogen can be found on the bottom-right corner. The figure is reproduced from reference [27]. 
 
2.1.2 Where can hydrogen be found?  
Hydrogen is the first and most abundant element in the universe and its mass fraction is 
estimated in the order of 75% and more than 90% by the number of atoms.[12] Even though space is 
filled with highly diluted hydrogen, gigantic gas clouds that consist of hydrogen and suns that release 
their radiant energy by “hydrogen burning”, the proportion of hydrogen on Earth is much smaller. The 
part of the Earth that is accessible to humans makes up only less than 1% of the Earth’s mass. The 
proportion of molecular hydrogen in the Earth’s atmosphere is only 0.5 parts per million (ppm). 
Furthermore, hydrogen on Earth exists only very rarely in its molecular form; it is commonly found in 
chemical compounds as hydrocarbons or water. In fact, the largest proportion of hydrogen on Earth 
can be found in the form of water.  
 
2.1.3 How can hydrogen be produced?  
Since hydrogen is only rarely found in its pure form, technologies were developed to produce 
chemically larger amounts of molecular hydrogen.[28–31] Most ways of producing hydrogen still rely on 
fossil fuels. The most widespread procedure is steam-reforming of natural gas, whereby methane and 
water react at high temperatures (1000-1400 K) to yield carbon monoxide and three equivalents of 
dihydrogen (CH4 + H2O → CO + 3 H2).[32] Not only are hydrocarbons used as a hydrogen source, 
energy is needed to sustain the required high temperatures and CO is produced as a byproduct. 
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Electrolysis of water is another way of producing clean hydrogen, hence two molecules of water are 
reassembled into one molecule of oxygen at the anode and two molecules of hydrogen at the 
cathode.[33] When the electric energy is gained by renewable energies (i.e. solar energy), this process 
is the cleanest way of producing molecular hydrogen. However, the electrodes required for electrolysis 
are made from noble metals as platinum and are thus expensive. 
Homogeneous catalysts that can produce molecular hydrogen either electrochemically or 
photochemically have been developed within the last decades (see below). They are very attractive 
since their chemical and photochemical properties can be scrutinized and tuned on a molecular level. 
Moreover, in homogeneous systems, catalysts may be covalently bound to photosensitizers, which 
could lead to more efficient electron transfer. Thus, molecular devices for water splitting based on 
such systems are of great interest, especially those relying on Earth-abundant metals.  
Nature itself utilizes a more sophisticated system to store the sun’s energy in chemical bonds. 
A process known as photosynthesis splits water and stores solar energy in chemical bonds. 
 
2.2 Natural Photosynthesis 
Photosynthesis is nature’s way to transform solar energy into storable chemical energy. This 
process is the foundation for higher life-forms. Photosynthesis takes place in plants, algae and 
cyanobacteria, where sunlight is used to produce high-energy chemicals as proteins and sugars from 
carbon dioxide and water. Not only 100 billion tons of biomass are produced by photosynthesis 
annually, but its “waste product” dioxygen is what most living aerobic organisms rely on for 
respiration.[34] Also, fossil fuels, such as oil, natural gas, and coal originate from photosynthetic 
activity.[35] The success of natural photosynthesis can be traced back to the fact that sunlight, water, 
and carbon dioxide are available in abundant quantities on Earth. The process of photosynthesis can 
be divided into two separate processes, the light-dependent reaction and the light-independent 
reaction, where carbon dioxide is fixed. The light-dependent reaction takes place in the thylakoid 
membrane of chloroplasts. The absorbed solar energy is used to drive an electron transport chain to 
oxidize water to dioxygen and to afford reducing equivalents NADPH, which can be viewed as the 
biological equivalent of molecular hydrogen. Since the oxidation of water at the oxygen evolving 
complex (OEC) requires strong oxidants, and the reduction of NADP+ to NADPH requires a 
relatively strong reductant, the light-driven reaction is split into photosystem I (PSI) and photosystem 
II (PSII). Both systems contain a central pair of chlorophyll molecules (P700 for PS I and P680 for PS 
II) in close van der Waals distance. This dimer of chlorophyll molecules is often referred to as the 
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“special pair” and it is enclosed by several well-organized chromophores. These chromophores harvest 
as much light as possible and transfer their energy to the embedded reaction center.[36] The so-called 
Z-scheme (Figure 2.2) provides a schematic overview on the spatial separation and the energy levels 
in PS I and PS II.[22,37] Once photo-excited, either by direct light absorption or by transduction of 
singlet excited state energy from antenna pigments, the reaction center injects an electron to a 
neighboring pheophytin.[38] Electron-transfer processes tend to be rather slow over large distances 
and, thus, have to be non-competitive with other energy-consuming reactions. To overcome this 
challenge, photosynthetic organisms have developed sequences of short-range electron transfer 
events, which eventually generate long-lived transmembrane charge-separated states. The initial 
electron transfer from the special pair of PSII to a neighboring pheophytin for instance occurs within 
3 ps. 
 
 
Figure 2.2: The Z-scheme illustrating electron transport in photosynthesis. The scheme shows the light absorbing units 
PSI and PSII, the electron transport chain, the oxygen evolving centre (OEC) and the NADP+ reductase. The figure is 
reproduced from reference [19]. 
 
The reduced pheophytin transfers its electron to an electron-accepting plastoquinone Q 
within a few hundred picoseconds. Plastoquinone accepts two electrons and two protons to yield 
plastoquinol QH2 in the micro- to millisecond time scale.[37] Afterwards, it diffuses from the reaction 
center to the cytochrome b6f complex. As the electrons are shuttled through the electron transport 
chain this complex, together with a plastocyanin, releases energy to produce a chemiosmotic potential 
by pumping protons across the membrane and into the thylakoid space. An ATP synthase enzyme 
uses that chemiosmotic potential to produce ATP from ADP during photophosphorylation.[39] ATP 
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is required, along with NADPH, to convert CO2 into energy-rich carbohydrates.[40] The oxidized 
special pair is re-reduced to its neutral form via a redox-active tyrosine, which channels electrons from 
the oxygen evolving complex.[41,42] Oxygen evolution is triggered by four sequential photon absorption 
events at a nearby antenna array.[43] Each photon that is absorbed and delivered to the reaction center 
results in 1 e− oxidation of the OEC. Following buildup of four oxidative equivalents at the OEC leads 
to O2 evolution. The oxidation is accompanied by proton loss and release from the OEC through a 
proton exit channel that avoids local charge buildup. The gained electrons, are then transferred to a 
chlorophyll molecule in Photosystem I. There, it is further excited by the light absorbed by that 
photosystem. The electron is then passed along a chain of FeS-clusters functioning as electron 
acceptors. During this process, some of the energy is used to move hydrogen ions across the thylakoid 
membrane into the lumen. The electron is eventually used to reduce the co-enzyme NADP+ with a H+ 
to NADPH, which has functions in the light-independent reaction. 
Since decades, the goal of research groups worldwide is to understand and mimic this 
sophisticated machinery. The key concepts, which are typically borrowed from natural photosynthesis 
in order to achieve efficient artificial solar to chemical energy conversion, are: i) light harvesting, ii) 
energy transfer, and iii) electron transfer. 
 
2.3 Artificial Photosynthesis 
2.3.1 Photocatalytic water splitting 
Photocatalytic water splitting is a very attractive method to store solar energy in chemical 
bonds.[44–47] This and related approaches are often referred to as artificial photosynthesis.[18–20] A full 
functioning water splitting system consists of a photosensitizer (PS) which acts as a photo-activated 
"electron pump", a water oxidation catalysts (WOC) which oxidizes H2O to O2 and protons and a 
water reducing catalyst (WRC) which reduces protons to H2 (Scheme 2.1). It turned out to be highly 
challenging to drive both half reactions of this highly complex process with artificial molecular 
catalysts simultaneously. Molecular approaches are often supported by the use of materials.[48–52] A 
completely homogeneous molecular water splitting system will most probably not work since back-
electron transfer between the O2 and H2 evolving half reactions will short-ciruit the whole system.[19] 
Light-driven, full water splitting was mainly achieved photo-electrochemically with heterogeneous 
semiconductors or dye-sensitized materials.[53] This is why, especially for homogeneous, molecular-
based water splitting, both half-reactions are investigated separately by replacing the WOC by a 
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sacrificial electron donor (SED) for water reduction and the WRC by a sacrificial electron acceptor 
(SEA) for water oxidation.[54–59]  
 
 
Scheme 2.1: Schematic representation of a complete water splitting system: (i) when the photosensitizer (PS) is excited 
by light (PS*) it oxidizes a water oxidation catalyst (WOC) after excitation, (ii) the oxidized WOC itself oxidizes water to 
yield oxygen and four protons, (iii) the reduced PS reduces a water reduction catalyst (WRC) and (iv) the reduced WRC 
is then reducing protons to eventually form dihydrogen. The Scheme was adapted from reference [60]. 
 
2.3.2 Photocatalytic water oxidation  
Photocatalytic water oxidation is a highly complex process, since four electrons have to be 
transferred. Two water molecules are transformed into one oxygen molecule and four protons as well 
as four electrons (2 H2O → O2 + 4 H+ + 4 e-). This process is more difficult to achieve than the two-
electron proton reduction (see below) and is considered to be the bottleneck to obtain a full water-
splitting device. Water oxidation catalysts are often investigated electrochemically or using ceric 
ammonium nitrate [(NH4)2Ce(NO3)6]-driven chemical water oxidation at low pH values. 
Photocatalytic oxygen evolution is most often performed with [Ru(bpy)3]Cl2 1 as a photosensitizer 
(PS, see below) and sodium peroxodisulfate (Na2S2O8) as sacrificial electron donor. Up to now, the 
most efficient and stable molecular WOCs are ruthenium-based complexes.[61] Catalysts based on 
earth abundant metals such as manganese, cobalt and copper have also been reported.[19] 
 
2.3.3 Photocatalytic water reduction  
Photocatalytic water or proton reduction is a two-electron process in which the protons are 
reduced to molecular hydrogen (2 H+ + 2 e- → H2). In the last decade, aqueous photo-catalytic 
hydrogen production was thoroughly scrutinized. Various PS and WRC have been investigated and 
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the performance of this half reaction was constantly improved. However, only a few SEDs have been 
discovered so far; mainly ascorbate (AscO-) 2, triethanolamine (TEOA) 3 or trialkylamines are used 
(Figure 2.3).[62] Under slightly basic conditions, amines are used for photo-catalysis and are 
irreversibly oxidized to products that do not interfere with the catalytic cycle. For acidic pH-values, 
ascorbic acid (AscOH), also known as vitamin C, is mainly used as SED.[63,64] When ascorbate is 
oxidized, it forms dehydroascorbic acid (DHA) 4 which can again be reduced, thus regenerating 
ascorbic acid (i.e. TCEP (tris(2-carboxyethyl)phosphine) 5).[60] 
 
 
Figure 2.3: Some commonly used sacrificial electron donors (ascorbic acid 2, triethanolamine 3 and TCEP 5) and the 
oxidized form of ascorbic acid 4. 
 
The AscOH-DHA pair is a quasi-reversible e--donor and can cause undesired back electron-
transfer from reduced PS or WRC to DHA which inhibits catalysis.[65] WRCs have been widely 
explored over the last years and for photo- and electrocatalysis various complexes based on earth-
abundant metals including cobalt, nickel, iron or molybdenum have been reported (see below). Three 
key parameters are crucial for a good catalytic performance: i) long term stability of the WRC, which 
is characterized by the turnover number (TON, H2/WRC), ii) the amount of hydrogen molecules 
produced per WRC over time (turnover frequency or TOF, in s-1 or h-1) and iii) a catalyst that only 
requires a low overpotential to produce molecular hydrogen. The overpotential describes the 
potential at which the WRC reduces protons compared to the thermodynamic potential of H+ 
reduction. Artero and Savéant could show, that the TOF and the overpotential are interdependent: 
the higher the applied overpotential, the higher the TOF.[66] 
 
2.3.4 Photosensitizers 
The first step of an artificial photosynthetic system is light-harvesting by a chromophore. Such 
a light-absorbing component is analogous to the photosynthetic pigments. This chromophore should 
efficiently absorb and convert the incoming solar energy into a long-lived excited state that can transfer 
an electron to an acceptor for the creation of a charge-separated state, thus generating the required 
thermodynamic driving force for the desired chemical reactions. Both, photo-active molecular dyes 
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and semiconductors can favor electron transfer and may be used as light-harvesting chromophores in 
a future artificial device for H2O splitting. Molecular photosensitizers are mainly based on precious 
metals, including: ruthenium 1, rhenium 6, iridium 7, rhodium or platinum, but also organic dyes such 
as Eosin Y 8 or Rose Bengal 9 have been investigated (Figure 2.4).[67–70] In the last few years, also 
homo- and heteroleptic Cu(I) complexes as 10 were used as noble metal-free molecular PS.[71–75] 
 
 
Figure 2.4: Structures of some commonly used noble metal-based photosensitizers (top), organic photosensitizers Eosin 
Y and Rose Bengal, as well as a homoleptic copper-based photosensitizer (R = s-butyl) used for solar hydrogen production. 
The well-known [Ru(bpy)3]Cl2 1 was used as a photosensitizer in the course of this work 
 
Yet, the most well-studied molecular photosensitizers for electron-transfer processes are the 
ruthenium(II) polypyridyl, [Ru(bpy)3]2+-type complexes (bpy = 2,2′-bipyridine).[67,76–78] These 
complexes have been studied since the early 1970s when it was discovered that they could undergo 
electron transfer from their excited states to a sacrificial electron acceptor.[79,80] This opened new 
possibilities and these complexes have been used in various applications ever since, also in the field of 
photo-redox catalysis.[81–85] These photosensitizers have a distinct absorption in the visible region (λmax 
≈ 450 nm), and upon illumination, one electron in a metal-centered t2g-orbital is excited to a ligand-
centered π*-orbital. In this metal-to-ligand charge transfer state (MLCT), the ruthenium center has 
formally been photo-oxidized to Ru(III), while the bipyridyl ligand has undergone a single electron 
reduction.  
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Scheme 2.2: Schematic overview of the photochemistry of [Ru(bpy)3]2+. Excited [Ru(bpy)3]2+ The figure is reproduced 
from reference [21].  
 
The initial photo-generated state, the lowest excited singlet state (1[Ru(bpy)3]2+*), is short-
lived and undergoes a rapid intersystem crossing to yield a long-lived triplet state, 3[Ru(bpy)3]2+*, that 
has the potential to take part in a single-electron transfer.[70] The electronic configuration of this 
excited state has almost only triplet character and can be described as a 3[(dπ)5(πbpy*)1]-state. Since the 
conversion back to the singlet state is spin-forbidden and decays to the ground state on the 
microsecond timescale, the lifetime of the excited triplet state is long. It is sufficiently long to engage 
in bimolecular electron-transfer reactions. The photo-excited state is more oxidizing and more 
reducing than the ground state of [Ru(bpy)3]2+. This dual nature of the excited state makes it serve 
either as a single-electron oxidant or reductant, as can be seen in Scheme 2.2.[21,86–89] This unique 
property of [Ru(bpy)3]2+-type complexes coupled with their redox properties, chemical stability, 
excited-state reactivity, excited-state lifetime and synthetic flexibility makes them highly versatile and 
attractive for both photo-oxidation and photo-reduction.  
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2.4 Natural Hydrogenases 
Hydrogenases are a group of natural occurring metalloenzymes than can catalyze one of the 
simplest molecular reactions: the conversion of two protons and two electrons into molecular 
hydrogen and the reverse reaction (Eq. I).[90–92] 
 
 
 
This reaction occurs at a specialized metal cluster that increases the acidity of H2 dramatically 
and is strongly accelerated by a nearby base. Dihydrogen formation involves the coupling of H- and 
H+ and its heterolytic mechanism has been confirmed by H/D isotope exchange experiments.[93] 
Hydrogenases can be found in archaea, bacteria and some eukarya and can be divided into three 
classes, depending on the metal ion composition of their active site, hence [Fe], [FeFe] and [NiFe] 
hydrogenases.[90–92,94–98]  
[Fe] hydrogenases are found in methanogenic archaea only. They also contain four different 
[NiFe] hydrogenases, but [Fe] hydrogenases are upregulated under conditions with low nickel 
concentrations.[99] The enzyme catalyzes one of the reaction steps in the methanogenic energy 
conversion pathway from carbon dioxide with H2 to methane.[94] The reaction is the reversible 
reduction of the substrate methenyltetrahydromethanopterin (methenyl-H4MPT+) with H2 to 
methylene-H4MPT and a proton (Figure 2.5 and Scheme 2.3).[100] Therefore, [Fe] hydrogenases are 
also referred to as: “H2-forming methylenetetrahydromethanopterin (methylene-H4MPT) de- 
hydrogenase” (Hmd). The enzyme harbors a unique Fe-cofactor (Fe-guanylylpyrodinol, Fe-GP) and 
does not contain any iron−sulfur clusters. The iron atom in [Fe] hydrogenases has CO ligands bound 
and displays an unusual coordination sphere.[101–103]  
 
2 H+ + 2 e- H2 (Eq. I)
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Figure 2.5: (a) X-ray structure of the dimeric Methanocaldococcus jannaschii (Mj) [Fe] hydrogenase (C176A) with the 
substrate (methylene-H4MPT) in its open form (PDB 3H65).[104] The Fe-GP cofactor and the substrate are shown by 
sphere representation. (b) The chemical structure of the Fe-GP cofactor. The possible H2-binding site is indicated as “X”. 
The figure was taken from reference [92]. 
 
Its structure and catalytic reaction mechanism differ from that of [NiFe] or [FeFe] 
hydrogenases,[105] and its activity is dependent on the substrate, methenyl-H4MPT+. The enzyme does 
not reduce electron acceptors like artificial dyes and the H2 activation occurs only in the presence of 
the substrate.[101]. 
 
Scheme 2.3:  Reaction of methenyl-H4MPT+ with H2. The [Fe] hydrogenase catalyzes the reversible reduction of the 
substrate methenyltetrahydromethanopterin (methenyl-H4MPT+) with H2 to methylene-H4MPT and a proton by 
transferring a hydride ion to the proR position of the C14a-carbon of methylene-H4MPT. The figure was taken from 
reference [92]. 
 
The iron atoms in [FeFe] and [NiFe] hydrogenases are ligated by CN- and CO and the metal 
centers are bridged by sulfur atoms (Figure 2.6).[106–108] The ligands help to tune the metal centers for 
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optimal interaction with H2 and to bind the heterolytically generated H- terminally to Fe. The resulting 
proton on the other hand is transferred to a pendant amine base in the azadithiolate ligand. CN- and 
CO are strong-field ligands which lead to low-spin Fe complexes.[108–111] Simultaneously, they provide 
empty acceptor orbitals for the two extra electrons of the forming hydride. The hydride acceptor 
ability of the metal is adjusted by fine-tuning the energies of the orbitals by either a charged CN- ligand 
or a CO ligand serving as a s-donor and p-acceptor.  
The pendant amine in close proximity of the metal center, whose basicity is fine-tuned by the 
binding geometry and the surrounding of the nitrogen, acts as a base. The secrets of the high hydrogen 
splitting and formation efficiency of those hydrogenases are the geometrical arrangement of the base 
as well as the electronic fine-tuning of the metal site and the base.[112] Even small changes in this highly-
evolved system can lead to drastic reduction in activity and stability. 
 
 
Figure 2.6: Structures of the [NiFe] hydrogenase from DvMF[113] and of the [FeFe][114] hydrogenase from Dd. The 
electron transfer chain (via iron−sulfur centers) is schematically indicated as well as pathways for dihydrogen and the H+ 
transfer. The chemical structures of the active sites of the two classes of hydrogenases; arrows indicate the open metal 
coordination site for hydrogen to bind. The figure is reproduced from reference [92]. 
 
Hydrogenases can be found in the cytoplasm or periplasm, membrane-bound or in soluble 
form.[115] The primary functions of hydrogenases are to balance the redox potential of a cell and to 
provide energy for the organism by the oxidation of molecular hydrogen. They can split H2 and 
provide electrons or they can remove reducing equivalents by the production of molecular hydrogen. 
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Hydrogenases can be tuned either for hydrogen oxidation or hydrogen reduction, depending on the 
location in the cell. Most purified hydrogenases that show catalytic activity are catalyzing the reaction 
in both ways, depending on the physiological context in the cell. 
While [NiFe] hydrogenases are usually more active in H2 oxidation [FeFe] hydrogenases are 
better in producing dihydrogen.[90,115] Some [FeFe] hydrogenases show extremely high turn-over 
frequencies of ~104 molecules of H2 per second at room temperature.[116,117] Their catalytic center is 
oriented in a highly-optimized protein environment that not only provides ligands for the metals but 
also orthogonal channels for electron transfer, proton transfer and dihydrogen transfer. Efficient 
electron delivery to or from the active site in [FeFe] hydrogenases is achieved by a directly bound 
[4Fe-4S] center which acts as an electron wire. Even though there are certain hydrogenase species that 
are oxygen-tolerant, most hydrogenases are inhibited by traces of molecular oxygen, especially the 
[FeFe] hydrogenases.[118,119] Most [NiFe] hydrogenases are reversibly inhibited by molecular oxygen 
and can be restored in a reducing atmosphere. Furthermore, these enzymes are prone to denaturation 
if not used at certain pH values or temperatures. All this, and the fact that their synthesis and 
purification is not trivial, encouraged scientists try to mimic their unique reactivity. 
 
2.5 Bioinspired Hydrogenase Model Systems 
When the crystal structures of the [FeFe] and [NiFe] hydrogenases in the late nineties and of 
the [Fe] hydrogenase in 2008 were published, chemists started to mimic the active sites of the 
enzymes.[120–122] Due to the complex arrangement around the metal core, it was challenging to 
synthesize functional models. The active site of all hydrogenases is deeply buried in the protein 
scaffold and provides a hydrophobic pocket. The hydrogenase itself, is perfectly tailored for the 
reaction to occur by providing channels for hydrogen, acidic and basic residues and H2O molecules 
for the proton transfer and a pathway for electrons through FeS clusters. It seems contra intuitive to 
assume that a hydrogenase mimic would thus be working in aqueous solution. The key features of a 
[FeFe] hydrogenase mimic, which should be prone to hydrogen evolution, should have are i) 
stabilization of an open coordination site where H2 can bind, ii) a base in close proximity to shuttle 
protons and iii) a contact site for external redox partners. A bridging amine had a beneficial impact in 
many cases.  
Despite the hundreds of structural models developed to date, only a few have shown 
electrocatalytic activity related to proton reduction or hydrogen oxidation.[123,124] Yet, many [FeFe] 
hydrogenase analogs have been reported that actually do undergo electrocatalytic hydrogen 
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evolution.[125,126] Rauchfuss and coworkers reported in 2001 the first di-iron dithiolate system, [Fe2[µ-
S2(CH2)3](CN)(CO)4(PMe3)] 11, which evolved hydrogen catalytically (Figure 2.7).[127] 
 
 
Figure 2.7: The first di-iron dithiolate system [Fe2[µ-S2(CH2)3](CN)(CO)4(PMe3)] 11, mimicking the active site of 
[FeFe] hydrogenases with catalytic activity, reported by Rauchfuss. 
 
However, the efficiency of this system is far below that of the natural hydrogenase. Following this 
work, many related systems have been reported that display electrocatalytic activity. Mostly, however, 
they operate with relatively large overpotentials.[124,128] Nevertheless, these models have helped to 
understand the roles of bridging thiolate ligands and the hydride-binding modes associated with their 
catalytic function.[123]  
More than 50 structural mimics of [NiFe] hydrogenases have been reported. In the beginning, 
mostly biomimetic complexes that differed significantly from the enzyme structure showed 
electrocatalytic behavior.[129–138] More recently, two competent Ni–Fe catalysts were reported that 
mimic both the structure and function of active [NiFe] hydrogenase.[139,140] A nickel–iron dithiolato 
hydride [(CO)3Fe(pdt)(µ-H)Ni(dppe)]+ 12 (pdt = 1,3-propandithiolate, dppe = 1,2-C2H4(PPh2)2) 
from the Rauchfuss lab is an active catalyst for the reduction of trifluoroacetic acid in CH2Cl2 (Figure 
2.8).[139] Catalytic activity of another nickel–iron dithiolato complex [Ni(xbsms)FeCp(CO)]+ 13 
(H2xbsms = 1,2-bis(4-mercapto-3,3-dimethyl-2-thiabutyl)benzene, Figure 2.8) with a chelating S4-
ligand was reported by Fontecave and Artero, with catalysis observed with trifluoroacetic acid in 
dimethylformamide (DMF).[140]  
 
 
Figure 2.8: [NiFe] hydrogenase active site mimics (left) [(CO)3Fe(pdt)(µ-H)Ni(dppe)]+ 12 shows electrocatalytic 
activity towards hydrogen evolution from trifluoracetic acid in CH2Cl2; (right) [Ni(xbsms)FeCp(CO)]+ 13, an active 
iron-nickel containing electrocatalyst for hydrogen evolution from trifluoracetic acid in DMF. 
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Several non-biomimetic systems display high efficiencies for H2 evolution. The most 
successful molecular and noble-metal free ones are Co-[55,59,141–145], Ni-[143,146–148] and Mo-[149,150] based 
systems (Figure 2.9). The mononuclear nickel complex [Ni(PPh2NPh2)2]2+ 19, with non-
coordinating pendant amines incorporated into the backbone of cyclic diphosphane ligands is highly 
active for catalytic hydrogen evolution, with a reported turnover frequency of 350 s-1under optimal 
conditions.[151–153] This is comparable to those of natural [NiFe] hydrogenase enzymes. Mechanistic 
studies suggest that the pendant amines act as a proton relay to the metal site, stabilize dihydrogen 
binding, and lower the barrier for heterolytic formation and cleavage of dihydrogen. This functionality 
in the second coordination sphere leads to much higher turnover rates and lower overpotentials than 
with complexes lacking those pendant bases.[153–157] 
 
 
Figure 2.9: Structures of selected noble metal-free water reduction catalysts. Top (from left to right): iron- based 
hydrogenase mimic 14 and nickel/cobalt diimine-dioxime (for cobalt: Cobaloxime) type complexes 15 and 16. Bottom: 
Molybdenum dithiolato complex 17, polypyridine based cobalt WRC 18 and DuBois-type nickel complex 19.  
 
Other mimics rely on cobalt with nitrogen-based ligands and have been reported to be active 
hydrogen-evolution catalysts. These complexes usually involve imine, oxime, glyoxime or polypyridin 
ligands. Cobalt diglyoxime, also known as cobaloximes, and polypiridyl complexes are promising 
molecules that evolve hydrogen in both aqueous and organic media (Figure 2.9).[142,144] They are not 
only electrocatalytically active but also photo-catalytically. Catalyst 17 for instance displays turnover 
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numbers exceeding 30.000 when TCEP is used in combination with ascorbic acid acting as an electron 
relay.[158]  
While good progress was made by mimicking the [FeFe] and [NiFe] active site, there are still 
difficulties to adapt to the protein scaffold responsible for the transport of substrates, products and 
electrons. One possibility would be to assemble a synthetic hydrogen evolving complex within a 
protein scaffold and thus enhance its reactivity. The result of incorporating a metallocofactor into a 
protein scaffold is commonly referred to artificial metalloenzymes (ArM).[159] 
 
2.6 Towards artificial hydrogenase enzymes 
2.6.1 Artificial Metalloenzymes 
Pioneering work in 1976 by Kaiser as well as Whitesides and Wilson resulted in a blooming 
new strategy to create artificial enzymes.[160,161] The resulting second coordination sphere resulting 
from incorporation can interact with the metal catalyst, substrates, intermediates or products to 
facilitate reactions or to discriminate similarly reactive moieties on substrates.[162] Furthermore, since 
the homogenous small molecule catalyst is incorporated into a genetically-encoded protein matrix, 
the performance of the ArM can be improved by mutagenesis.[163–166] Relying on this technique, ArMs 
can lead to systems suitable for practical application and provide insights in how a second coordination 
sphere influences the performance of organometallic catalysts. 
There are four complementary strategies commonly used to integrate a metallic cofactor within a 
well-defined second coordination sphere environment provided by a host protein (Figure 2.10): 
(i) Covalent anchoring involves an irreversible and high-yielding reaction between a 
cofactor bearing a reactive functional group and an amino acid on the protein scaffold.[167] 
Some commonly used reactions used to form an ArM are a) nucleophilic attack of a 
cysteine or another activated residue on the protein on an electrophilic moiety on the 
cofactor, b) disulfide bond formation of a protein bound cysteine and a nucleophilic sulfur 
containing cofactor and c) “click”-reaction between an unnatural amino acid bearing a 
terminal azide (or alkyne) with an alkyne (or azide) bearing cofactor.[168–170]  
(ii) Supramolecular anchoring makes use of the high affinity some proteins (host) display 
for certain non-covalent inhibitors, substrates or natural cofactors (guest). Covalent 
modification of these with a cofactor may retain the affinity for the protein, ensuring a 
quantitative incorporation of the cofactor within the host protein. Since no chemical 
modification step is required after the incorporation of the cofactor the integrity of the 
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organometallic species is retained. A perfect example of this supramolecular anchoring is 
represented by the biotin-streptavidin technology.[168] 
(iii) Dative anchoring stands for the coordination of a coordinately unsaturated metal center 
to one or more nucleophilic amino acid residues (Asp, Cys, Glu, His, Ser, etc.). This 
strategy is often complemented by either supramolecular or covalent strategies.[161,171] 
(iv) Metal substitution refers to a unique activity a non-native metal combined with a 
uniquely tailored active site of a natural metalloenzyme. The substitution of the metal 
center can catalyze new-to-nature reactions.[172–175] 
 
 
Figure 2.10: The four anchoring strategies to introduce an abiotic cofactor within a protein scaffold: (a) covalent, (b) 
supramolecular, (c) dative, and (d) metal substitution. Color codes: protein and natural cofactor (green), supramolecular 
anchor (red), variable spacer and ligand (blue), and abiotic metal (black). The figure is reproduced from reference [159]. 
 
2.6.2 Biotin-Streptavidin Technology 
As mentioned before, the supramolecular anchoring strategy involves strong and specific 
interactions between the tetrameric protein streptavidin and its substrate biotin 20 (Figure 2.11). It 
turned out that the biotin-(strept)avidin system is a perfect couple to assemble artificial 
metalloenzymes. In the late 80s Whitesides and Wilson used this technology to create the first artificial 
metalloenzyme.[160] They converted avidin into an enantioselective catalyst by incorporating a 
biotinylated achiral rhodium-diphosphine complex into the biotin-binding pocket. Due to the fact 
that due to the following reasons:  
i) The affinity of (strept)avidin for biotin is the strongest non-covalent biological interaction 
known, with a supramolecular binding affinity of KA = ca. 1015 M-1 for avidin and KA = ca. 
1013 M-1 for streptavidin.[176–178] Derivatization of the valeric chain of biotin by the 
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introduction of linkers or by the modulation of the chelating residues does not alter its 
affinity dramatically.[179] 
ii) The protein shows exceptional tolerance towards environment changes, which allows to 
utilize the technology on a large variation of different reactions. A biotin-loaded 
streptavidin survives temperatures up to 110°C for several minutes, and is not completely 
denatured under extreme pH conditions (6 M guanidinium chloride at pH 1.5) and can 
tolerate high concentrations of organic solvents (up to 50% EtOH) and the presence of 
surfactants (i.e. sodium dodecyl sulphate, SDS).[176,177,180,181] 
iii) The modular approach of the biotin-streptavidin technology allows for a fairly 
straightforward way to optimize the system, since the cofactor can be modified separately 
and the protein can be mutated by genetic means and bioconjugation.  
iv) The access to the protein is an important parameter in the creation of metalloenzymes. 
Streptavidin, which is naturally secreted by Streptomyces avidinii bacteria, can be readily 
expressed from E. coli cultures and produced as recombinant protein with high yields (up 
to 8.3 grams per liter of E. coli culture).[182,183] Avidin, naturally available from egg 
white,[177] on the other hand is difficult to produce in bacteria, but reasonable yields can 
be obtained in yeast cells as Pichia pastoris.[184] Because of their stability, they are easy to 
purify by affinity chromatography using immobilized iminobiotin. 
  
Figure 2.11: The biotin-streptavidin technology: (left) the biotin molecule (also known as vitamin H) that can be bound 
to abiotic cofactors via its carboxylic acid moiety; (middle cartoon representation of a streptavidin monomer with an 
incorporated biotin molecule (red stick representation); (right) surface representation of tetrameric streptavidin with an 
incorporporated biotin molecule (red stick representation); (pdb code: 3PK2).[185] 
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Avidin and streptavidin share an amino acid similarity of only 41% but have almost identical 
secondary, tertiary and quaternary structures.[176,186,187] Both fold in an eight-stranded antiparallel beta-
barrel and their quaternary structure is composed of four identical barrels. Each subunit has a single 
biotin-binding site placed near one end of the barrel. The binding site provides a perfect fit for the 
biotin molecule (also known as vitamin B7, vitamin H or coenzyme R).[188] Even when no biotin is 
bound the involved amino acids are already pre-organized to accommodate the biotin molecule. 
Following biotin-binding, a flexible loop located between the strands  3 and  4 becomes ordered, 
locking the biotin molecule in the binding site. Given the fact that the isoelectric points (pI) differ in 
both proteins streptavidin (pI = 6.2) is preferred over avidin (pI = 10.4) for many biological 
applications.[189] ArMs based on the biotin-streptavidin technology have been developed to catalyze a 
wide variety of water compatible reactions including: hydrogenation,[190] olefin metathesis,[191] 
sulfoxidation,[192] dihydroxylation,[193] asymmetric allylic alkylation,[194] Suzuki-coupling,[195] C–H 
activation[196] and transfer hydrogenation.[185,197] 
 
2.6.3 Artificial Hydrogenase mimics 
The concept of artificially assembling a small molecule cofactor into a protein scaffold to 
produce hydrogen has been explored so far.[198–203]  
One possibility is the artificial synthesis of natural hydrogenases. Promising results were 
achieved by Fontecave and co-workers with the [FeFe]-hydrogenase HydA. The formation of its di-
iron catalytic site (or H-cluster) requires a complete maturation machinery of many different 
enzymes, involving at least HydE, HydG, and HydF. The exogenous ligands (CO, CN−, aza-
propanedithiol) are introduced by HydE and HydG. HydF serves as the host protein in which the di-
iron complex is finally assembled. In the last step, the nearly mature di-iron complex is transferred to 
apo-HydA. Fontecave and co-workers showed that a hydrogenase could be maturated in vitro, without 
the maturation machinery involved. By loading an inactive artificial di-iron cofactor into apo-HydF, 
they could transfer the synthetic complex into the apo form of the hydrogenase HydA, reconstituting 
a fully active HydA (Scheme 2.4a).[204] Those results also show, that the central atom of the bridging 
dithiolate ligand must be a nitrogen, since only then catalytic activity was detected (X in Scheme 2.4a). 
Fontecave and Happe could even show that the use of HydF could be avoided. They demonstrated 
that a direct loading of a synthetic complex into apo-HydA is possible (Scheme 2.4b).[205] Hu and co-
workers built on this strategy and reported the direct formation of an [Fe]-hydrogenase by loading its 
apo-form with a synthetic complex (Scheme 2.4c).[206] 
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These findings show that it is indeed possible to generate an active hydrogenase without the 
need of its complex enzymatic maturation machinery. This opens the possibility of expressing 
hydrogenases in a heterologous organism and opening the possibility of introducing a fully synthetic 
cofactor within an apo-hydrogenase. This will allow for large screening libraries of hydrogenases (i.e. 
by directed evolution) resulting in variants with higher activity and/or oxygen-tolerance. Hu and 
Lubitz could already demonstrate, that small variations of the cofactor lead, in most cases, to inactive 
hydrogenases.[207] This will help to understand the complexity of these systems and lead eventually to 
more active artificial hydrogenases. 
 
 
Scheme 2.4: Reconstitution of apo-hydrogenases with synthetic cofactors affords functional hydrogenases, demonstrated 
either by (a) the use of less maturation enzymes, (b) direct loading of a synthetic complex into apo-HydA or by (c) direct 
formation of an [Fe]-hydrogenase by loading its apo-form with a synthetic complex. This scheme was taken from reference 
[159]. 
This strategy seems promising, yet the complexity and the size of the scaffold are limiting. A 
scaffold that is reduced to its minimum size would be favorable for industrial applications, especially 
systems that are stable over a wide range of conditions. Other groups explored the possibility of 
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assembling synthetic complexes within various protein scaffolds to produce hydrogen. Yet, only a 
limited amount of catalysts and protein scaffolds have  been investigated until now.[159]  
The group of Hayashi et al. for example inserted active site [FeFe] hydrogenase mimics into 
various host proteins.[203] By datively anchoring a di-iron complex into the active site of apo-
cytochrome c, they were able to afford an active hydrogenase containing a [(μ-S)2Fe2(CO)6]-moiety 
(Scheme 2.5). The protein contains a Fe-protoporphyrin(IX) cofactor that is covalently attached to 
the protein via a thioether linkage at a Cys-X2-Cys motif, where X are other amino acids. Catalytically 
inactive [Fe2(CO)9] 21 was bound to the Cys-X2-Cys motif of the apo-cytochrome c after removal of 
the heme. When [Ru(bpy)3]2+ 1 was added as a PS and ascorbic acid 2 as sacrificial electron donor, 
the ArM produced hydrogen (82 TON after 2 h) with a maximal TOF of 0.035 s-1. When, on the other 
hand, a synthetic heptapeptide containing the Cys-X2-Cys motif and a His residue to mimic the active 
site of cytochrome c was utilized, lower activities were achieved (4-fold lower TOF and 8-fold lower 
TON). This demonstrates the protective role of the protein scaffold. 
 
 
Scheme 2.5: Dative and covalent anchoring of 21 and 22 afford photo-catalytically active [FeFe] hydrogenase mimics. 
 
When a more rigid scaffold was used to create an artificial hydrogenase, hence anchoring the 
di-iron cofactor 22 via a maleimide linker to an artificially introduced cysteine of aponitrobidin Q96C, 
showed a TON of 120 after 2 h (130 after 6 h) and a maximum TOF of 0.038 s-1 upon irradiation.[208] 
However, when the free cofactor was irradiated under similar conditions, it performed three times 
faster and catalysis ceased after 2 h with a TON of 130. The decreased accessibility of the cofactor 
inside the protein probably reduces the rate of electron transfer from the PS. Even though there is a 
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clear decrease in rate, the protein matrix provides a stabilizing environment, making the catalyst last 
three times as long. 
Bren and coworkers substituted iron by cobalt in enzymes containing iron-
protoporphyrin(IX) which afforded active hydrogenases.[209] Eventually, the catalysts showed a longer 
catalyst lifetime inside the protein (24 h against 4 h) and 10-fold higher TON (11.000 against 1.000) 
in electrocatalysis experiments. However, the incorporation into a protein scaffold did not lower the 
high overpotential required (830 mV against 850 mV). 
A cobalt-substituted myoglobin was used by Ghirlanda et al.. They could show that, upon 
irradiation at pH 7.0 in the presence of ascorbate and a photosensitizer, the host protein increased the 
TON compared to the free cofactor by the factor of 4.3, hence 518 in 12 h.[209]  
Artero et al. explored a similar strategy in incorporating cobaloximes 23 and 24 into the apo 
form of sperm whale myoglobin.[210] They could show that the catalysts occupied the heme-site to 
form 23·Mb and 24·Mb. When photochemical hydrogen production was performed using deazaflavin 
(DAF hereafter) and tris-buffer (pH 7) as electron donor 24·Mb performed up to 5 TON in 15 min. 
However, the free cofactor 24 outperformed the artificial hydrogenase (TON 8.3). Other heme-
binding proteins were also investigated, hence rat heme oxygenase 1 (HO1 hereafter) and 
Corynebacterium diphteriae heme oxygenase (HmuO hereafter).[210] The resulting artificial 
hydrogenases 24·HO1 (6.3 TON) and 24·HmuO (15.3 TON) were more active than 24·Mb (5.0 
TON) under photochemical conditions. However, the free catalyst 24 afforded 20 TON. The reason 
for this could be that the protein shields the catalyst and disturbs the interaction between the PS and 
the incorporated catalyst. Furthermore, the catalyst was deactivated rapidly. The authors hypothesize 
that the Co(III)−H intermediate could reduce the oxime ligand itself. The lifetime of this intermediate 
could be shortened if the electron transfer to the catalyst could be accelerated and thus preventing 
ligand degradation. One way to achieve this would be to keep the catalyst and the PS in close proximity 
to enable fast electron transfer. 
 
    27 
 
Scheme 2.6: Cobaloximes are highly active hydrogen production catalyst. They can be anchored via a histidine or a 
methionine residue of the apo-heme protein.  
 
This strategy was addressed by Utschig et al. making use of the affinity of 25 (Scheme 2.6) and 
26 (Figure 2.12) towards the photosystem I (PSI hereafter).[211,212] PSI, a component of the naturally 
occurring photosynthetic electron transport chain, contains a light-harvesting center and a series of 
electron relays, incorporated within a large protein matrix. The authors hypothesize that the 
interaction of the two catalysts and the PSI is non-covalent and hydrophobic patches of the PSI are 
involved. Upon irradiation of 25·PSI (which was obtained by incubation of PSI with 25), ascorbate 2 
(pH 6) and cytochrome c6 as electron transport, hydrogen evolution could be measured. This system 
performed 2080 TON in 1.5 h, with a maximum TOF of 1.13 s−1 and under similar conditions, 26·PSI 
performed 1870 TON in 3 h, relative to cobalt. In both cases however, analysis of the catalytic mixture 
upon completion of the reaction revealed that approximately 90% of the metal dissociated from the 
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protein. This is probably due to the poorly defined and weak interactions between PSI and those 
catalysts and catalytic degradation processes. 
 
 
Figure 2.12: Nickel Phosphines are synthetic complexes with high hydrogen production catalytic activity. They can be 
bound to PSI or Fld. 
 
In general, the artificial hydrogenases reported to date show that incorporating a proton-
reduction catalyst within a protein scaffold can, in some cases, increase TOF and TON in aqueous 
media at neutral pH. However, sometimes the artificial hydrogenases are less efficient than the 
cofactor alone. Especially for photocatalytic systems where the interactions between the PS and the 
catalyst are hindered, eventually leading to slow catalytic rates or catalyst degradation. Some 
advantageous issues of artificial hydrogenases need to be systematically explored. For instance, very 
few examples of random mutagenesis or directed evolution are reported.[213] Only few modifications 
in the immediate proximity of the metal center have been tested either by mutating residues or by 
testing different scaffolds from a same family (e.g. heme-binding proteins). Most importantly, none of 
these examples led to a dramatic improvement of catalytic activity. In a biomimetic spirit, artificial 
hydrogenases could be improved by engineering facilitated pathways for proton or electron delivery 
or removal at the metal center and gas release pathways, resembling the channels and electron relays 
present in natural hydrogenases. So far, no efforts have been undertaken to utilize the biotin-
(strept)avidin technology as a scaffold for artificial hydrogenases. 
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2.7 Aim of this thesis 
Climate change is the ultimate proof that mankind has to change its way of producing energy. 
To use the suns radiant energy and store it in chemical bonds between hydrogen molecules has 
become a fashionable and sustainable way of doing so. Artificial photosynthesis or photocatalytic 
water splitting, and mimicking nature is one way of overcoming that problem. Synthetic hydrogen 
evolving mimics of the catalytic center of hydrogen producing enzymes were developed, yet they lack 
the second coordination sphere of those enzymes. This second coordination sphere provides gas and 
proton channels as well as electron relays and electron transporting pathways. They are the reason for 
their incredible activity. The goals of this thesis are: 
 
(i) Exploring the biocompatibility of hydrogen evolution catalysts from formic acid in under 
biological friendly conditions. 
(ii) Exploring electron transfer pathways of bio-conjugated assemblies of electron acceptors, 
electron donors and photosensitizers on the surface of streptavidin. 
(iii) Exploring the impact of a secondary coordination sphere of streptavidin on photocatalytic 
hydrogen evolution of an incorporated metalorganic catalyst. 
 
The findings should help to improve the progress in synthesizing and assembling nature-like 
hydrogenases to eventually solve the world energy problem.
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3.1 Abstract 
Formic acid is an attractive means to reversibly store dihydrogen. In this context, d6-pianostool 
complexes rank among the most effective formate dehydrogenase catalysts. With biologically 
produced formic acid in mind, we evaluated the performance of iridium-based pianostool complexes 
bearing a cooperative ligand, known to catalyze formate decomposition. Interestingly, the phenyl-
pyrazine derived catalyst [Cp*Ir(phenpz)(OH2)]+ 7 compares favorably with the very best systems 
[Cp*Ir(phenpz(CO2H))H2O]+ 8 and [Cp*Ir(imim)H2O]2+ 11. These catalysts display remarkable 
air tolerance, recyclability and activity under dilute aqueous conditions. 
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3.2 Introduction 
Hydrogen is an attractive, clean and renewable energy vector. In this context, formic acid has 
been identified as a promising, safe and easy to handle hydrogen storage medium.[214–220] The reversible 
catalytic decomposition of formic acid yields dihydrogen and carbon dioxide and is mediated by 
organometallic catalysts. In particular, d6-pianostool complexes have demonstrated their versatility as 
formate dehydrogenases.[221–229] These studies are, however, typically performed using high formic 
acid concentrations. 
In a biological context, formic acid can be produced metabolically from glucose via a pyruvate 
lyase mechanism.[230–232] With the long-term goal of producing bio-hydrogen in vivo via a 
chemoenzymatic cascade,[233] we set out to compare and evaluate the performance of d6-pianostool 
complexes at low formate, potentially biologically relevant concentrations.  
 
3.3 Results and Discussion 
Scrutiny of the literature revealed that many of the most promising organometallic formate 
dehydrogenase catalysts possess ligands that contain a basic functionality (B:). In a biomimetic spirit, 
dihydrogen is reversibly mobilized as a metal hydride and a protonated ligand.[116,234] The ligands 
selected for this study and their corresponding complexes 1-12 are displayed in Scheme 3.1. 
In order to evaluate the involvement of the cooperative ligand, complexes lacking the basic 
appendage (B:) were synthesized and evaluated as well: [Cp*Ir(bpy)(OH2)]2+ 2, 
[Cp*Ir(phenpy)(OH2)]+ 4 and [Cp*Ir(phenpz)(OH2)]+ 7. Complexes 1-12 were prepared 
according to literature protocols (see Appendix A for further information). For comparison purposes, 
all complexes 1-12 were isolated as aquo complexes with (hydrogen)sulfate as counteranion.  
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Scheme 3.1: Catalytic decomposition of formate to dihydrogen and carbon dioxide is catalyzed by d6-pianostool 
complexes. Ligands and corresponding complexes screened in this study. 
 
Most studies to date are performed in pure formic acid or high concentration of formate 
solutions. In order to mimic in vivo formate decomposition, biocompatible reaction conditions were 
selected: buffered solutions (pH 4.0), 37 °C, and either 230 mM or 45 mM formate (Appendix A). 
Screening complexes 1-12 for their formate dehydrogenase was achieved by determining the gas 
evolution[235] revealed the following trends (Figure 3.1): 
i) The presence of a bidentate ligand is indispensable to ensure activity for the d6 Ir-pianostool 
moiety, as reflected by the poor performance of [Cp*Ir(OH2)3]2+. In the presence of a bidentate 
ligand, the {Cp*Ir(III)} derived catalysts 1-11 clearly outperform the {Cp*Rh(III)} congener 
(compare [Cp*Ir(phenpzCO2H)H2O]+ 8 with [Cp*Rh(phenpzCO2H)H2O]+ 12). 
 ii) Using 45.5 mM formate, complexes [Cp*Ir(bpy(OH)2)H2O]2+ 3, 
[Cp*Ir(phenpy(CO2H)H2O]+ 6, [Cp*Ir(phenpz)H2O]+ 7, [Cp*Ir(phenpz(CO2H) )H2O]+ 8 and 
[Cp*Ir(imim)H2O]2+ 11 yield similar turnover numbers (i.e. > 40 TON) after 180 minutes in the 
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presence of 0.9 mM catalyst (2.0 % loading). It is interesting to note that complex 
[Cp*Ir(phenpz)H2O]+ 7 which lacks a basic moiety on the ligand ranks among the best catalysts after 
three hours. 
 iii) Increasing the concentration to 230 mM formate in the presence of 0.9 mM catalyst 
further highlights the superiority of [Cp*Ir(phenpz(CO2H))H2O]+ 8 and [Cp*Ir(imim)H2O]2+ 11 
over all other catalysts tested. Again here, [Cp*Ir(phenpz)H2O]+ 7, which lacks a basic appendage, is 
the third best catalyst. 
iv) Comparing conversions after 30 minutes reveal marked differences among complexes 
[Cp*Ir(bpy(OH)2)H2O]2+ 3, [Cp*Ir(phenpy(CO2H)H2O]+ 6, [Cp*Ir(phenpz)H2O]+ 7, 
[Cp*Ir(phenpz(CO2H))H2O]+ 8 and [Cp*Ir(tosen) )H2O]+ 9 and [Cp*Ir(imim)H2O]2+ 11 
suggesting that complex [Cp*Ir(phenpz(CO2H))H2O]+ 8 displays the highest reaction rates.  
Next, we selected the most promising catalysts [Cp*Ir(bpy(OH)2)H2O]2+ 3, 
[Cp*Ir(phenpz)H2O]+ 7, [Cp*Ir(phenpz(CO2H))H2O]+ 8 and [Cp*Ir(tosen) )H2O]+ 9 and 
[Cp*Ir(imim)H2O]2+ 11 and determined their first-order rate constants for the decomposition of 
formic acid, Figure 3.2 and Table 3.1 (See Appendix A for details). Although complex 
[Cp*Ir(tosen)H2O]+ 9 has the highest initial activity, it rapidly levels off after ca. 35 turnovers. 
Complexes [Cp*Ir(phenpz(CO2H))H2O]+ 8 and [Cp*Ir(imim)H2O]2+ 11 display similar rates and 
higher turnover numbers. 
 
 
Figure 3.1: Formate dehydrogenase properties of complexes 1-12. The TONs were determined after 30 min (hatched 
bars) and 180 min (solid bars) using 0.0455 M formic acid and 2 mol % catalyst at pH 4 and 37 °C (a); and 0.23 M formic 
acid and 0.4 mol % catalyst at pH 4 and 37 °C (b). 
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Figure 3.2: Formate dehydrogenase activity catalysed by [Cp*Ir(bpy(OH)2)H2O]2+ 3 (black), [Cp*Ir(phenpz)H2O]+ 
7 (red), [Cp*Ir(phenpz(CO2H))H2O]+ 8 (green) and [Cp*Ir(tosen))H2O]+ 9 (blue) and [Cp*Ir(imim)H2O]2+ 11 
(turquoise). The solid lines were obtained by fitting the gas evolution using a first-order rate equation in OriginPro 9 (see 
Appendix A for details). Reaction conditions: 45.5 mM formic acid and 0.9 mM catalyst in a 2.5 M acetic acid/sodium 
acetate buffer at pH 4 and 37°C. 
Having identified [Cp*Ir(phenpz(CO2H))H2O]+ 8 and [Cp*Ir(imim)H2O]2+ 11 as the 
most active catalysts, their recyclability was evaluated, Figure 3.3. For this purpose, a reaction vessel 
was charged with 45.5 mM formic acid (0.1 mmol) and 0.9 mM catalyst 8 (2% catalyst loading) in a 
2.5 M acetic acid/sodium acetate buffer at pH 4 and 37 °C. After gas evolution had ceased, the vessel 
was recharged with 0.1 mmol formate. The reaction was run to completion for each four recycling 
experiments. As can be appreciated, [Cp*Ir(imim)H2O]2+ 11 outperforms 
[Cp*Ir(phenpz(CO2H))H2O]+ 8 as its decomposition rate does not erode over time, Figure 3.3.  
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Table 3.1: First-order rate constants for the catalytic decomposition of formic acid[a] 
Complex Rate constants (s-1) 
[Cp*Ir(bpy(OH)2)H2O]2+ 3 k = 1.60·10-4 ± 1.56·10-7  
[Cp*Ir(phenpz)H2O]+ 7 k = 2.16·10-4 ± 2.28·10-7  
[Cp*Ir(phenpz(CO2H))H2O]+ 8 k = 6.85·10-4 ± 6.01·10-7  
[Cp*Ir(tosen))H2O]+ 9  k = 8.7·10-4 [b]  
[Cp*Ir(imim)H2O]2+ 11 k = 5.28·10-4 ± 6.06·10-7 
[a] Reaction conditions: 45.5 mM formic acid and 0.9 mM catalyst in a 2.5 M acetic acid/sodium acetate buffer 
at pH 4 and 37°C; [b] The catalyst deactivates after ca. 35 TONs, the rate was thus estimated from the half life 
by k = ln 2/t1/2 
 
In order to evaluate the air-tolerance of catalysts [Cp*Ir(phenpzCO2H)H2O]+ 8 and 
[Cp*Ir(imim)H2O]2+ 11, reactions were carried out i) under nitrogen atmosphere, ii) under air, iii) 
in an air-saturated solution and iv) using catalyst solution allowed to stand on the bench for three 
weeks. All tolerance tests resulted in similar results, the TON after thirty minutes varied by less than 
ten percent, highlighting the robustness of [Cp*Ir(phenpzCO2H)H2O]+ 8 and [Cp*Ir(imim)H2O]2+ 
11. Upon reducing the catalyst concentration from 910 µM to 2.3 µM (i.e. 0.4% to 0.001%), the TON 
after thirty minutes increased from 159 to 710 in both cases. Using 9 µM 
[Cp*Ir(phenpzCO2H)H2O]+ 8 and [Cp*Ir(imim)H2O]2+ 11,  > 3650 and > 8700 turnovers were 
achieved respectively within 48 hours. With biological applications in mind, we evaluated the activity 
of [Cp*Ir(phenpzCO2H)H2O]+ 8 in pure water. Upon increasing the pH, the TON after three hours 
decreased from 250 (pH 4.0), 204 (pH 5.0) to 147 (pure water). Repeating the experiment with 
[Cp*Ir(imim)H2O]2+ 11, the TON after three hours displayed a different trend, namely from 250 
(pH 4.0), 47 (pH 5.0) to 250 (pure water), highlighting its versatility under non-buffered conditions.  
 Further insight into the mechanism of the catalysis and the stability of the catalysts was 
obtained by monitoring the formate conversion by NMR. [Cp*Ir(phenpzCO2H)H2O]+ 8  and 
[Cp*Ir(imim)H2O]2+ 11 were allowed to react at room temperature at a concentration of 910 µM 
with sodium formate 45.5 mM in pure water (95% H2O + 5% D2O) or in acetic acid-d4 buffered water 
(pH 4.0). In all cases a pronounced shift of the 1H resonances of the complex were observed after the 
addition of formate and within several minutes a low intensity resonance at –11.51 ppm indicated the 
formation of an iridium hydride species. The attachment of the ligands to the iridium Cp* moiety was 
deduced by NOE contacts of the ligand with the Cp* methyl protons. In the time course of 24 hours 
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the resonances of the complexes and the hydride signal remained virtually unchanged while the 
formate signal at 8.34 ppm steadily decreased (Figure A.3). Using deuterium labeled NaDCOO 
nevertheless yielded the hydride signal at –11.51 ppm and, in addition, the HCOO resonance 
appeared after 1 hour, indicating an iridium catalyzed H-D-exchange of the formate. In order to follow 
the formate conversion also by 13C-NMR, 13C-labeled sodium formate was used for the reaction.  
 
 
Figure 3.3: Recyclability of [Cp*Ir(phenpzCO2H)H2O]+ 8 a); and [Cp*Ir(imim)H2O]2+ 11 b) towards formate 
dehydrogenase (0.1 mmol formate added at each recharging step). The arrows indicate the recharging of the flask with 0.1 
mmol formate in 200 µL water.  
 
The formate resonance at 170.5 ppm slowly disappeared while a new resonance at 124.7 ppm 
was observed which is conclusive for the formation of carbon dioxide. No trace of carbon monoxide 
(181.3 ppm) was observed during the reaction. To independently determine whether CO is produced 
under the chosen reaction conditions a modified spot test with phosphomolybdic acid and PdCl2 was 
performed but showed no CO evolution of complexes 8 and 11 (Appendix A). These findings are 
consistent with previous reports.[226,236] 
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3.4 Conclusions 
With the aim of identifying the most effective d6 pianostool complex for formate 
dehydrogenase in dilute formic acid, we evaluated the performance of twelve different catalysts. Both 
[Cp*Ir(phenpzCO2H)H2O]+ 8 and [Cp*Ir(imim)H2O]2+ 11 performed very well yielding up to > 
3650 TON and > 8700 TON respectively. With biological applications in mind, these catalysts were 
shown to be air tolerant and display activity under near physiological conditions. Current efforts are 
aimed at evaluating these catalyst’s performance in the presence of engineered cells producing formic 
acid. 
 
3.5 Experimental Section 
All syntheses were conducted under nitrogen. All chemicals were used as purchased. 
Complexes 1, 2, 3, 4, 5, 7, 8, 9, 10 and 11 were synthesized according to literature procedures 
(Supporting Information). 
 
3.5.1 Synthesis of [Cp*Ir(phenpyCO2H)(H2O)]+ (6) 
To N2 sparged water (12 ml), was added a solution of [Cp*IrCl2]2 (0.292 mmol) in 
acetonitrile (5 ml) and the ligand (0.584 mmol). Ag2SO4 (0.584 mmol) was added and the reaction 
mixture was heated to reflux overnight. The reaction solution was allowed to cool to room 
temperature and centrifuged for 6 min at 4400 rpm. The supernatant was decanted and filtered 
through a 0.45 micron filter. The organic solvent was removed under reduced pressure and the water 
was removed by lyophylization. The resulting yellow solid was collected (286 mg, 97.6 %).  
 
1H NMR (400 MHz, DMSO-d6): δ = 1.69 (s, 15H), 2.07 (s, 3H), 7.58 (t, J = 6.4 Hz, 1 H), 7.81 (d, J 
= 8.0 Hz, 1 H), 8.14 (d, J = 8.2 Hz, 1 H), 8.20 (t, J = 7.8 Hz, 1 H), 8.23 (s, 1 H), 8.44 (d, J = 8.2 Hz, 1 
H), 8.82 (d, J = 5.6 Hz, 1 H), 11.35 (br, 1 H); 13C NMR (101 MHz, DMSO-d6): δ = 167.20, 165.13, 
154.05, 152.31, 149.13, 140.85, 135.96, 132.36, 126.20, 125.62, 125.32, 121.90, 118.04, 96.25 (5C), 
8.19 (5C), 1.14; EA found: C, 40.46; H, 4.37; N, 3.61. Calc. for C24H27IrN2O6S + 3 H2O: C, 40.16; H, 
4.63; N, 3.90%; HRMS (ESI+) calcd. for C22H23IrNO2, 526.1358; found, 526.1353. 
 
3.5.2 Synthesis of [Cp*Rh(phenpzCO2H)(H2O)]+ (12) 
To N2 sparged water (12 ml) was added a solution of [Cp*RhCl2]2 (0.292 mmol) in 
acetonitrile (5 ml) and the ligand (0.584 mmol). Ag2SO4 (0.584 mmol) was added and the reaction 
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mixture was heated to reflux overnight. The reaction solution was allowed to cool to room 
temperature and afterwards centrifuged for 6 min at 4400 rpm. The supernatant was decanted and 
filtered through a 0.45 micron filter. The organic solvent was removed under reduced pressure and 
the water was removed by lyophylization. The resulting orange solid was collected (218 mg, 66.3 %). 
 
1H NMR (400 MHz, Methanol-d4) δ = 1.74 (s, 15 H), 2.05 (s, 3 H), 6.83 (s, 1 H), 7.62 (d, J = 8.3 Hz, 
1 H), 7.91 (d, J = 8.3 Hz, 1 H), 8.20-8.62 (br, 2 H), 8.65 (d, J = 2.8 Hz, 1 H); 13C NMR (101 MHz, 
Methanol-d4) δ = 169.01, 153.20 (d, J = 31.8 Hz), 146.34, 144.88, 139.69, 131.13, 131.03, 129.55 , 
118.29, 114.03 , 112.22 , 103.96 (d, J = 5.7 Hz, 5 C), 9.09 (5 C), 0.88; EA found: C, 43.48; H, 5.34; 
N, 6.73. Calc. for C22H26N3O6RhS + 2 H2O: C, 44.08; H, 5.34; N, 6.73%; HRMS (ESI+) calcd. for 
C20H22NO2Rh, 425.0733; found, 425.0731. 
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4.1 Abstract 
Electron transfer from a biotinylated electron donor to photochemically generated Ru(III) 
complexes covalently anchored to streptavidin is demonstrated by means of time-resolved laser 
spectroscopy. Through site-selective mutagenesis, a single cysteine residue was engineered at four 
different positions on streptavidin, and a Ru(II) tris-diimine complex was then bioconjugated to the 
exposed cysteines. A biotinylated triarylamine electron donor was added to the Ru(II)-modified 
streptavidins to afford dyads localized within a streptavidin host. The resulting systems were subjected 
to electron transfer studies. In some of the explored mutants, the phototriggered electron transfer 
between triarylamine and Ru(III) is complete within 10 ns, thus highlighting the potential of such 
artificial metalloenzymes to perform photoredox catalysis. 
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4.2 Introduction 
Streptavidin (hereafter Sav) is an exquisitely robust protein of ca. 64 kDa comprised of four 
homologous sub-units, each of which can bind a biotin molecule with an association constant of ~1014 
M-1 under physiological conditions.[237] Sav can readily be over-expressed and purified from the 
bacterium Escherichia coli. Owing to this combination of favorable properties, biotin-streptavidin 
systems have been exploited in various contexts where host-guest recognition is desirable, ranging 
from targeted drug delivery, to live cell imaging and new applications in catalysis.[238] 
By biotinylation of small metal catalysts, novel catalytic functions can be conferred to the 
resulting biotin-streptavidin assemblies, resulting in artificial metalloenzymes.[239–241] Their function 
can be tailored either chemically, i. e., through variation of the biotin-linker-catalyst moiety, or 
genetically through site-specific mutagenesis of Sav. In the best case, such chemogenetic optimization 
can lead to catalytic performance which is superior to that observed for the related small metal catalyst 
outside the protected environment of the biotin binding pockets of Sav, manifesting for example in 
unusually high enantioselectivity.[156,242] 
In principle, such artificial metalloenzymes should also be amenable to the emerging field of 
redox photocatalysis,[82,84,243] and for this purpose it would be desirable to equip the biotin-streptavidin 
systems with redox photosensitizers. Complexes of d6 metal ions such as ruthenium(II) and 
iridium(III) are good candidates in this regard.  
There have been several studies of the luminescence properties of biotinylated d6 metal 
complexes, including ruthenium(II) polypyridines,[244–247] rhenium(I) tricarbonyl diimines,[248–252] 
and cyclometalated iridium(III) complexes.[253–258] In most cases, binding to streptavidin leads to 
enhanced luminescence properties, and this is important for example for cell imaging purposes.[259,260] 
The above mentioned classes of metal complexes are well suited for photosensitization of electron 
transfer reactions,[261] but, to the best of our knowledge, this has not yet been realized within the 
context of the biotin-streptavidin technology.[262] However, ruthenium(II) and rhenium(I) complexes 
have been employed frequently for investigation of phototriggered electron-transfer in other proteins 
(e. g., azurin, cytochrome c, or plastocyanin), mostly for distance-dependence studies and for 
elucidating electron tunneling pathways.[263–268] The ruthenium(II) and rhenium(I) metal centers 
were commonly ligated to histidine ligands for this purpose, and the natural redox-active groups of 
these proteins (e. g., blue copper centers or heme groups) served as electron-transfer reaction 
partners. 
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Typical photoredox systems usually require a photosensitizer combined with a distinct 
catalytic moiety. As the binding of biotinylated probes to Sav is non-cooperative, introducing two 
distinct dyads within a streptavidin tetramer remains an unmet challenge.[179] To assemble such dyads 
using a Sav scaffold, we thus opted to bioconjugate the photosensitizer to an engineered cysteine 
residue, thus leaving the four biotin-binding sites of Sav free to introduce either a catalytic or an 
electron-donor moiety. 
As Sav possesses no cysteine residue, site-directed mutagenesis was used to engineer this highly 
nucleophilic residue at selected positions. The resulting single-point mutants were subsequently 
bioconjugated with a [Ru(bpy)2(phen)]2+-photosensitizer 1 (Figure 4.1, bpy = 2,2’-bipyridine, phen 
= 1,10-phenanthroline). The triarylamine (TAA) unit was equipped with a biotin group to yield Biot-
TAA (see Appendix B for details, 2 displayed in Figure 4.1). The resulting Biot-TAA / Ru(II)-
streptavidin adducts are donor-acceptor systems in which photo-triggered electron transfer can be 
investigated. The goal of this work was to explore whether photo-triggered electron injection from a 
biotinylated donor to ruthenium(II)-labeled streptavidin is possible and if so, what position on the 
surface of Sav is most suitable for the covalent anchoring of the photosensitizer.  
 
4.3 Results and Discussion 
4.3.1 Structural and synthetic aspects 
The ruthenium(II) complex (rac-1 displayed in Figure 4.1) was covalently tethered to 
streptavidin through nucleophilic attack by a cysteine residue with concomitant elimination of 
HBr.[269] Single cysteine residues were introduced by site directed mutagenesis on each of the four 
homologous units of streptavidin, leading to a fourfold Ru(II)-labeling of each streptavidin tetramer. 
The biotinylated triarylamine unit Biot-TAA was synthesized as a binding partner. The acetyl-
substituted triarylamine (TAA-Ac) 3 served as a reference compound (Figure 4.1). Syntheses and 
mutagenesis procedures are presented in the Appendix B. 
 
  44 
 
Figure 4.1: Chemical structures of the ruthenium(II)-label for streptavidin 1, the Biot-TAA moiety 2 (biotin is displayed 
in blue) and the TAA-Ac reference molecule 3. See Appendix B for syntheses. 
 
Inspection of the X-ray structure of S112A Sav (pdb code: 3PK2)[185] led us to select four 
positions for the introduction of a cysteine residue by site-directed mutagenesis. The following four 
mutants were produced using a previously published method and purified by affinity 
chromatography[270] and characterized by ESI-MS: Sav T66C, R84C, S112C, and K121C (Figure 
4.2).  
Subsequent bioconjugation was achieved by mixing the mutant protein overnight with an 
eightfold excess of Ru-complex 1 at 4°C in phosphate buffer (50 mM, pH 7) in the dark. The excess 
of the unbound Ru-complex 1 was removed by dialysis and the resulting Ru4Sav bioconjugates 
(Ru4Sav T66C, Ru4Sav R84C, Ru4Sav S112C, and Ru4Sav K121C respectively) were characterized by 
ESI-MS, revealing a quantitative conversion to the Ru-containing proteins (see Appendix B for 
details). The biotin-binding capacity of the Ru4Sav bioconjugates was assessed relying on a 
displacement titration using HABA (2-(4-hydroxyphenylazo)benzoic acid). Upon incorporation 
within Sav, HABA displays an absorption at lmax 506 nm. Upon addition of biotinylated probes, the 
HABA is displaced, leading to a disappearance of the absorption at 506 nm.[187,242] This simple 
procedure revealed that all four biotin-binding sites can accommodate the biotinylated cofactor Biot-
TAA, and the affinity is similar to that of pure unmodified biotin (see Figure 4.3, more details in the 
Appendix B). 
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Figure 4.2: Surface display representation of homotetrameric streptavidin, highlighting the symmetry related positions 
selected for introducing cysteine residues: K121 (orange), S112 (yellow), R84 (blue), T66 (green) and biotin (red stick 
representation); (pdb code: 3PK2).[185]  
 
This confirms that the bulky Biot-TAA moieties bind to Ru4Sav isoforms, despite the 
presence of the bulky Ru(bpy)2(phenNHCOCH2) moieties which, in the S112C and K121C 
mutants, lie in the proximity of the biotin-binding vestibule. 
 
Figure 4.3: HABA displacement titrations of biotin (black symbols) and the biotinylated triarylamine Biot-TAA (red 
symbols) for a) WT streptavidin and b) K121C-Ru (see Appendix B for experimental details). 
 
Since no crystal structure could be obtained so far, through-space distances were estimated 
based on a previously published crystal structure of an Ir-loaded streptavidin mutant (pdb code: 
3PK2).[185] The arylated biotin moiety bearing a para-sulfur atom was used for distance estimation. 
This latter sulfur atom was selected as a surrogate for the nitrogen atom of the Biot-TAA moiety 
(Figure B.16). The shortest through-space distances from the sulfur atom to the  -carbon of the amino 
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acids targeted for mutagenesis ranges from 7.1 to 22.1 Å (Table 4.1). As, by symmetry four cysteine 
residues result from a single point mutation, the mean value of the two closest residues was also 
determined: it increases from K121 (7.9 Å) < S112 (9.5 Å) < R84 (18.3 Å) < T66 (20.0 Å). 
 
Table 4.1. Estimated through-space distances between a-carbon atom of the targeted mutagenesis positions and the 
sulfur atom of a biotinylated cofactor based on the crystal structure of streptavidin (pdb code: 3PK2)[185]. The two closest 
Ca are listed as well as their mean values (Figure B.16-B.20 in the Appendix B for details). 
mutant R1 [Å] R2 [Å] mean [Å] 
K121C 7.1 8.6 7.9 
S112C 6.9 12.1 9.5 
R84C 14.8 21.7 18.3 
T66C 17.8 22.1 20.0 
 
4.3.2 Electron transfer studies 
To explore the electron transfer in the Biot-TAA / Ru(II)-streptavidin dyads a flash quench 
technique was applied (Figure 4.4).[271–273]  
 
Figure 4.4: Illustration of the flash-quench procedure used for studying electron transfer in the Biot-TAA / Ru(II)-
streptavidin adducts.[263–268] MV2+ stands for methylviologene. 
 
Therefore, the ruthenium(II) photosensitizer was excited selectively at 532 nm with laser 
pulses of ~10 ns duration. In the presence of 120 mM methylviologen dichloride (MV2+) added to the 
aqueous solution, the luminescent 3MLCT excited state of the photosensitizer *Ru(II) is quenched 
oxidatively with diffusion-limited kinetics, i. e., initial excitation (“flash”) is followed by oxidation of 
*Ru(II) to Ru(III) (“quench”) within the ~10 ns duration of the laser pulse. 
    47 
In a sample containing 50 µM Ru(II)-streptavidin (K121C mutant) and 120 mM MV2+ but 
no Biot-TAA in MilliQ water at 25 °C, one observes the typical spectroscopic signatures of the MV●+ 
radical (green trace in Figure 4.5a).[274] Specifically, there is a sharp and intense absorption at 393 nm 
and a broader, less intense band with a maximum at 605 nm which can be attributed unambiguously 
to MV●+.[274,275] The oxidation product Ru(III) manifests as a bleach at ~450 nm. When adding 25 µM 
Biot-TAA to the same solution, an additional band at ~760 nm becomes observable (black trace in 
Figure 4.5a) in addition to the MV●+ bands.  
 
 
Figure 4.5: (a) Transient absorption spectra of K121C-Ru measured after excitation at 532 nm with laser pulses of ~10 
ns duration. The spectra were time-integrated over 200 ns immediately after excitation. Sample concentrations were: 50 
µM Ru(II)-streptavidin, 120 mM MV2+, 25 µM Biot-TAA or TAA-Ac, where applicable. The solvent was MilliQ water at 
25 °C. (b) Temporal evolution of the transient absorption signal at 760 nm for 3 of the 4 samples from (a). 
 
The band at 760 nm is typical for TAA+,21 and hence this is clear evidence for electron transfer 
from TAA to Ru(III), which (based on the relevant redox potentials)[276–282] is expected to be 
associated with a reaction free energy (∆GET0) of ca. -0.5 eV. In the reference experiment in which 50 
µM Ru(II)-streptavidin and 120 mM MV2+ were measured in the presence of 25 µM TAA-Ac, the 
band at 760 nm does not appear (blue trace in Figure 4.5a), confirming that in the Ru(II)-streptavidin 
(K121C mutant) / TAA-biotin system, the photo-triggered electron transfer from TAA to Ru(III) 
does indeed rely on the tight association between the streptavidin host and the Biot-TAA guest. 
The TAA+ signal at 760 nm rises with instrumentally limited kinetics (black trace in Figure 5b), 
indicating that phototriggered electron transfer from TAA-biotin to Ru(III)-streptavidin (K121C 
mutant) occurs with a rate constant kET ≥ 108 s-1. The signal then decays on a timescale > 10 µs, due to 
bimolecular electron transfer between Biot-TAA+ and MV●+ (Figure 4.5b). MV●+ has non-negligible 
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absorbance at 760 nm hence the observation of small signals even in absence of Biot-TAA (blue and 
green traces in Figure 4.5b). 
For the S112C mutant, qualitatively similar results are obtained (Supporting Information). 
There is clear indication for rapid (kET ≥ 108 s-1) electron transfer from Biot-TAA to Ru(III)-
streptavidin, and the resulting photoproduct is again very long-lived (> 10 µs). However, for the R84C 
and T66C mutants, no such evidence was obtained. We conclude that these two ruthenium(II)-
labeled mutants are not well suited for electron transfer with biotinylated triarylamine guests. These 
findings correlate with the increasing distances between the photosensitizer and the electron donating 
triarylamine. It is possible that electron transfer between photo-excited Ru(II) and MV2+ is less 
efficient in these cases even though they seem to be even better exposed as the Ru(II) complexes in 
the other two mutants. 
 
4.4 Summary and Conclusions 
Rapid photo-triggered electron transfer from biotinylated guests to ruthenium photosensitizers 
which are covalently attached to cysteine residues of streptavidin is possible in carefully selected 
mutants. This is an important finding in view of photo-redox catalysis which makes use of catalysts 
which are embedded in the protected environment of a biotin binding pocket of streptavidin and 
photosensitizers which are bound to the surface of streptavidin. Catalysts in the biotin binding pocket 
can exhibit markedly better performance than outside streptavidin,[156,239] and our study paves the way 
to photo-redox catalysis in specifically engineered artificial metalloenzymes.  
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5.1 Abstract 
Long-lived photo-driven charge separation is demonstrated by assembling a triad on a protein 
scaffold. For this purpose, a biotinylated triarylamine was added to a Ru(II)- streptavidin conjugate 
bearing a methyl viologen electron acceptor covalently linked to the N-terminus of streptavidin. To 
improve the rate and lifetime of the electron transfer a negative patch consisting of up to three 
additional negatively charged amino acids was engineered via mutagenesis close to the biotin-binding 
pocket of streptavidin. Time-resolved laser spectroscopy revealed that the covalent attachment and 
the negative patch were beneficial for charge separation within the streptavidin hosted triad: the 
charge separated state was generated within the duration of the excitation laser pulse, and lifetimes up 
to 3120 ns could be achieved with the optimized supramolecular triad.  
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5.2 Introduction 
In nature, the multicomponent photosystems II and I (PS II, PS I) harvest the energy provided 
by the sun and convert it into cellular fuel NADH. In plant photosynthesis, the electrons for the 
reduction of NAD+ to NADH are provided by the oxidation of water, on the other side of the enzyme 
complex.[283] Upon light absorption, water is oxidized and the electrons are transferred via a cascade to 
the catalytic reduction site. All redox and electron transfer processes take place in specific and 
specialized protein environments. In a biomimetic spirit, artificial photosynthesis aims at: i) 
mimicking the performance and functionality of natural photosynthesis, ii) converting visible light 
into electrochemical energy and iii) storing the extracted energy as chemical fuels. To achieve this 
ambitious goal, the generation of long-lived charge-separated states is essential. If the resulting 
electron-hole pair recombination is slow, the produced generated potential can be valorized to drive 
chemical reactions. In the past forty years, significant effort has been invested by chemists to mimic 
the exquisitely complex photosynthetic reaction center.[284–287] For this purpose, covalent or 
supramolecular assembly of an electron acceptor (A), an electron donor (D) and a photosensitizer 
(PS) affords an artificial triad A–PS–D.[288,289] Upon photochemical irradiation, the excited state A–
PS*–D can react to afford the corresponding (transient) charge-separated species A¯–PS–D+. In a 
biomimetic spirit, we set out to exploit a protein scaffold to position all three components of an 
artificial triad. There are few examples of artificial dyads embedded within proteins or 
peptides;[201,211,283,290–295] but artificial intramolecular triads relying on a protein scaffold seem 
unexplored to the best of our knowledge.  
We selected streptavidin (Sav hereafter) as a scaffold for the assembly of such a triad. Sav is a 
remarkably stable and versatile homotetrameric protein (4 X 159 aminoacids, ca. 65 kDa). Each of the 
four identical monomers can bind one equivalent of biotin with a supramolecular binding affinity of 
KA = ca. 1013 M-1.[296] The biotin-(strept)avidin technology, commonly referred to as molecular velcro, 
draws its versatility from the remarkable affinity between biotinylated probes and (strept)avidin. 
Importantly, derivatization of the carboxylate of biotin by large probes does not affect significantly this 
remarkable affinity. Since its introduction by Bayer and Wilchek half a century ago, it has found 
numerous applications in live cell imaging, drug delivery, ELISA and pull-down assays.[237] 
Additionally, this technology was used in the past decade to anchor abiotic cofactors within a protein 
environment to create artificial metalloenzymes.[238,297–306] 
This effort was inspired by a visionary publication by Whitesides.[303,307–311] In a related context, 
several studies on the luminescence properties of (strept)avidin-embedded biotinylated d6-metal 
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complexes, including ruthenium(II) polypyridines,[247,312–314] rhenium(I) tricarbonyl diimines[249–
251,315,316] and cyclometalated iridium(III) complexes[256,258,317–320] suggest that such protein-based 
systems are well-suited for the generation of photo-induced charge separation.[321] 
 
 
Figure 5.1: Structures of the photosensitizer, the donor and the acceptor used with cysteine-bearing Sav mutants to create 
Sav-embedded triads. Cysteine-bound ruthenium(II) photosensitizer, (RuSav); biotinylated triarylamine Biot-TAA 
(biotin in blue), the TAA-NH2 used as reference, methyl viologen MV2+ and the methyl viologen analogue aMV2+ that 
was covalently bound to the N-terminus of Sav to afford RuSav–aMV2+ (see SI for synthesis and characterization). 
 
In a recent study,[322] we covalently anchored [Ru(bpy)2(phenNHCOCH2Br)](PF6)2 to 
four different Sav isoforms bearing a single cysteine residue per monomer (Figure 5.1). Upon addition 
of a biotinylated triarylamine Biot-TAA, acting as electron donor, and excess methyl viologen MV2+ 
as external electron acceptor, we could characterize, by transient absorption spectroscopy, the 
formation of charge-separated species by photo-induced electron transfer.  
By varying the position of the [Ru(diimine)3]2+ photosensitizer on the Sav scaffold (i. e. by 
testing four different cysteine-bearing Sav mutants), we could identify the most suitable Sav mutant 
that favored an efficient electron transfer, as detected by the photoproduct of the oxidized electron 
donor. To ensure efficient electron transfer however, the terminal acceptor MV2+ was added in a large 
excess to the solution containing the Sav-embedded dyad.[322]  
 Building on these results, we report herein on our efforts to assemble and optimize a 
supramolecular triad embedded within a streptavidin scaffold. 
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5.3 Results and Discussion 
5.3.1 Synthesis and structural aspects 
In order to improve the rate of the electron transfer as well as the lifetime of the charge-
separated species, we hypothesized that we may be able to combine both chemical- and genetic 
optimization strategies to assemble within streptavidin a triad.[297] With this goal in mind, we set out 
to covalently anchor aMV2+ to the N-terminus of Sav. We speculated that this strategy would increase 
the effective molarity of the terminal aMV2+ acceptor in the proximity of the biotinylated donor Biot-
TAA embedded within the Sav bearing a covalently bound photosensitizer. The resulting Sav-
embedded triad, abbreviated Biot-TAA × RuSav–aMV2+, was further optimized by genetic means. We 
hypothesized that engineering an anionic patch in the proximity of the biotin-binding vestibule 
(hosting both, the Biot-TAA and the [Ru(diimine)3]2+-moiety) may contribute to further increase 
the effective molarity of the terminal electron acceptor in the proximity of both photosensitizer and 
electron donor. This concept has been used by nature, where an accumulation of negatively charged 
amino acids (negative patch) on plastocyanin are proposed to be involved in recognition of 
physiological reaction partners as cytochrome f and Photosystem I.[323–325] The effect of both chemical 
and genetic optimizations of the triad was evaluated relying on time-resolved photo-excitation 
experiments. 
The ruthenium(II) complex [Ru(bpy)2(phenNHCOCH2Br)](PF6)2, the biotinylated 
supramolecular binding partner triarylamine Biot-TAA and the reference triarylamine TAA-NH2 
were synthesized as previously described (Figure 5.1).[322] The alkoxy-amine containing methyl 
viologen analogue aMV2+ was synthesized in 4 steps as detailed in the Appendix C (Scheme C.1 and 
Figures C.1-C.7). As previously demonstrated,[322] the dyad bearing the ruthenium photosensitizer 
covalently anchored at position K121C of Sav displayed the highest quantum yield of the oxidized 
Biot-TAA. We thus selected K121C Sav as a starting scaffold for all mutagenesis studies reported 
herein. Inspection of the X-ray structure of the mature S112A Sav (pdb code: 3PK2)[185] revealed a 
disordered N-terminus (i.e. residues 2-12, ASMTGGQQMGR). These residues were modelled using 
Yasara[326] and possessed an a-helical structure. To flexibilize this N-terminus, thus increasing the 
probability bringing the aMV2+ closer to the PS, we substituted the -QQMGRD- motif (residues 9-
14) by a -SGGGGS- sequence (N-flex hereafter). 
In a second step, to evaluate the effectiveness of a negative patch to bring the positively 
charged aMV2+ in the proximity of the biotin-binding vestibule, we engineered additional glutamate 
and aspartate residues at positions N82-Y83-R84 (Figure 5.2 and Figure C.8). These three residues 
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were identified using Yasara[326] as suitably positioned to allow the aMV2+ to reach the negative patch 
generated upon incremental introduction of Glu or Asp residues at these positions (Figure 5.2). 
 
  
Figure 5.2: Engineering a negative patch in the proximity of the biotin binding vestibule. Surface representation of 
homotetrameric streptavidin, highlighting the selected amino acids (N82-Y83-R84, red) for the introduction of a negative 
patch; the K121C position (yellow) for the introduction of the Ru(II) photosensitizer, the naturally occurring E51 
(orange) as well as biotin (blue, stick representation) (S112A mutant, the organometallic cofactor bound to the biotin was 
removed due to clarity, pdb: 3PK2).[185] 
 
We mutated, expressed and purified four different mutants using N-flex K121C Sav as 
template with either no (Sav0 hereafter), one (Sav1 hereafter, R84E), two (Sav2 hereafter, N82D-
R84E) or three (Sav3 hereafter, N82D-Y83E-R84E) additional carboxylate side chains (Figure 2). As 
the WT Sav contains a glutamate E51 in the proximity of the engineered negative patch, up to four 
negative charges may be present in the case of the N-flex-Sav3 mutant (highlighted in orange and red 
in Figure 5.2). The mutants were expressed using ZYP-5052 media, purified by affinity 
chromatography using iminobiotin-sepharose matrix and characterized by ESI-MS (details collected 
in the Appendix C, Figures C.10-C.17).[270,327] SDS-PAGE analysis using biotin-4-fluorescein 
demonstrated the biotin binding capability of the engineered Sav tetramers and highlighted a marked 
change in its isoelectric point pI as evidenced by the significant difference in electrophoretic mobility 
(Figure C.9).  
To covalently link the methyl viologen analogue aMV2+ to Sav's N–terminus, the versatile 
procedure developed by Francis et al. was slightly modified, Figure 5.3.[328] The procedure tolerated 
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the use of pyridoxal-5-phosphate PLP which, added in excess to a phosphate-buffered solution (50 
mM, pH 6.5) of the RuSav, resulted in the oxidation and hydrolysis of the N-terminal amine group to 
a ketone (Figure 5.3).  
 
 
Figure 5.3: Coupling a modified activated methyl viologen aMV2+ to the N-terminus of RuSav via a pyridoxal-5-
phosphate-mediated transformation to yield the methyl viologen containing conjugate RuSav–aMV2+. (a) 0.2 M PLP, 50 
mM PO43- buffer, pH 6.5, 37°C, 1 h (b) 250 mM aMV2+, 50 mM PO43- buffer, pH 2.2, 37°C, 1.5 h. 
 
After removal of excess PLP by ultrafiltration dialysis (10 kDa cut off), the resulting Sav 
bearing a single ketone functionality readily reacted with the alkoxyamine-bearing aMV2+, added in 
excess to a phosphate-buffered solution (50 mM, pH 2.2). The resulting oxime linkage is stable 
towards hydrolysis. The reaction was performed for one hour at 37°C and the resulting bioconjugates 
were purified via dialysis. Hereafter, we refer to the engineered Sav bioconjugates bearing the 
covalently attached [Ru(diimine)3]2+-photosensitizer as RuSavn and the covalently modified aMV2+ 
as RuSavn–aMV2+ (where n = 0, 1, 2 or 3).  
Since no crystal structure could be obtained so far, through-space distances were estimated 
based on a previously published crystal structure of an Ir-loaded streptavidin mutant (pdb code: 
3PK2).[54] In a similar fashion to our previous study,[50] the arylated biotin moiety bearing a para-sulfur 
atom was used for distance estimation (Figure C.18 and Table C.1). This latter sulfur atom was 
selected as a surrogate for the nitrogen atom of the Biot-TAA moiety. The through-space distances 
from the sulfur atom to the α-carbons of the K121 residues can be estimated to 7.1 Å and 8.6 Å 
respectively. The through space distances of the α-carbons of the K121 residues and the α-carbons of 
the closest negatively charged R84 residues were determined to be 18.7 Å and 22.0 Å respectively. 
Furthermore, the distances of the Biot-TAA itself and the negative patches are 14.8 Å and 21.7 Å 
respectively. Given the flexibility of the system those are rough estimates. 
The biotin-binding capacity of the RuSavn and the RuSavn–aMV2+ bioconjugates was 
evaluated relying on a displacement titration using 2-(4-hydroxyphenylazo)benzoic acid 
(HABA).[302,327,329] Upon incorporation within Sav, HABA displays an absorption at λmax = 506 nm. 
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Addition of a biotinylated probe displaces HABA, thus leading to the disappearance of the absorption 
band at 506 nm. This straightforward procedure revealed that each of the four biotin-binding sites of 
the homotetrameric Sav bioconjugates can accommodate one biotinylated cofactor Biot-TAA 
(Figure C.19 and C.20). Moreover, the affinity of Biot-TAA for RuSavn or RuSavn–aMV2+ (where n 
= 0 - 3) is comparable to that of biotin for WT Sav. This confirms that the bulky Biot-TAA moieties 
tightly bind to RuSavn and RuSavn–aMV2+ isoforms, despite the presence of the bulky 
[Ru(diimine)3]2+ moiety which lies in the immediate proximity of the biotin-binding vestibule. 
 
5.3.2 Optical spectroscopic studies 
UV/Vis transient absorption spectroscopy was used to explore photo-induced electron 
transfer in the streptavidin-based donor-photosensitizer-acceptor systems. Selective photoexcitation 
of the Ru(II) chromophore of the RuSavn–aMV2+ · Biot-TAA systems at 450 nm with laser pulses of 
~10 ns duration under deaerated conditions in milliQ water lead to the transient absorption spectra 
displayed in Figure 5.4.  
  
Figure 5.4: Transient absorption spectra of 50 µM of RuSav0–aMV2+ (black trace), RuSav1–aMV2+ (blue trace), RuSav2–
aMV2+ (green trace) and RuSav3–aMV2+ (red trace) in milliQ water at 25 °C, 10 µs after excitation at 450 nm in presence 
of 50 µM Biot-TAA. Spectra were time-integrated over 4 µs. 
 
The red trace in Figure 5.4, recorded with a time delay of 10 µs for the RuSav3–aMV2+ · Biot-
TAA system, exhibits the spectroscopic signatures expected for electron transfer between the TAA / 
MV2+ couple. In particular, the narrow intense band at around 400 nm as well as the weaker (broad) 
absorption around 605 nm are diagnostic for MV+,[330,331] while the band at 750 nm is characteristic for 
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TAA+.[332,333] Nearly identical transient absorption spectra are obtained for RuSav2–aMV2+ · Biot-
TAA (green trace) and RuSav1–aMV2+ · Biot-TAA (blue trace), i. e., the systems having only two or 
one single point mutations (instead of three) to introduce additional negative charge on the protein 
surface. Only the RuSav0–aMV2+ · Biot-TAA system (black trace) without any mutations produces 
weaker TAA+ and MV+ signals. The clear message extracted from these experiments is that long-lived 
charge-separation is readily achievable based on this design principle. Importantly, point mutations 
that increase the negative charge on the streptavidin surface are beneficial for formation of the desired 
photoproducts comprised of TAA+ / MV+ pairs. 
The quaternary structure of Sav consists of four sub-units that all harbour one 
[Ru(diimine)3]2+ photosensitizer, one TAA donor, and one methyl viologen acceptor. Thus, all our 
RuSavn–aMV2+ · Biot-TAA systems are conformationally flexible tetrads of triads, and this 
complicates the kinetic analysis for two obvious reasons: (i) conformational flexibility leads to 
multiple donor-sensitizer, sensitizer-acceptor, and donor-acceptor distances in different proteins and 
its sub-units; (ii) electron transfer can also occur between redox-active units attached to different sub-
units of Sav. Consequently, given the uncontrollable multitude of electron transfer distances and 
pathways, multi-exponential kinetics for formation and decay of the photoproducts are generally 
observed, unlike in rigid rod-like donor-sensitizer-acceptor compounds. It is thus not possible to 
extract rate constants for every individual photo-initiated processes in our streptavidin-based scaffolds 
in a meaningful manner. 
The general observation for the RuSavn–aMV2+ · Biot-TAA systems is that a substantial 
amount of TAA+ photoproduct (absorbing at 750 nm) is formed within the 10 ns duration of the laser 
pulse (Figure C.21), indicating that in a subset of triads electron transfer from TAA to the photo-
excited [Ru(diimine)3]2+ complex takes place with rate constants (k) exceeding 108 s-1. However, 
transient absorption spectra recorded immediately after photoexcitation are dominated by the 
signature of the 3MLCT state of the photosensitizer (Figure C.22), and based on this observation, we 
estimate that the subset undergoing photo-induced electron transfer amounts to roughly 10% at most 
under the conditions used for our experiments. Time-resolved luminescence data (Figure C.23) 
monitoring [Ru(diimine)3]2+ emission at 630 nm confirm that the 3MLCT excited-state is only 
partially quenched in the RuSavn–aMV2+ · Biot-TAA systems. The disappointingly low yield for TAA+ 
/ MV+ photoproduct formation likely has the following reasons: Electrostatic repulsion between the 
[Ru(diimine)3]2+ complex and the MV2+ unit in the conformationally flexible scaffolds is expected to 
lead to large [Ru(diimine)3]2+-MV2+ distances, disfavouring oxidative [Ru(diimine)3]2+ 3MLCT 
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excited-state quenching. Most of the 3MLCT quenching therefore likely occurs via a reductive 
pathway, i. e., electron donation from TAA. Within the subset of scaffolds undergoing primary 
electron transfer from TAA to photo-excited [Ru(diimine)3]2+, onward electron transfer from 
[Ru(diimine)3]+ to MV2+ is exergonic by -0.9 eV, but reverse electron transfer from [Ru(diimine)3]+ 
to TAA+ is thermodynamically even more favoured.[332,333] Indeed, the transient absorption kinetics in 
Figure C.24 suggest that 58-71% of the TAA+ signal at 750 nm decay very rapidly after the laser pulse 
(t » 20 ns; Table 5.1 and Appendix C Figures C.21, C.22, C.24 and-C.25), and this is attributed to 
thermal reverse electron transfer between [Ru(diimine)3]+ and TAA+. Time-resolved luminescence 
data are compatible with this interpretation (Figure C.26 and Table C.2). 
 
Table 1: Decay time constants (t1, t2, t3) of the charge-separated state RuSavn–MV+ · Biot-TAA+ (n = 0, 1, 2, 3) extracted 
from triexponential fits. In each case, there was an initial rapid decay with a time constant (t1) of ca. 20 ns, which leads to 
a rate constant of 5*107 s-1 for TAA+ to Ru(bpy)3+ (reverse) electron transfer as mentioned in the main text. The time 
constants t2 and t3 reflect the decay of the TAA+ / MV+ charge-separated state. 
 t1 [ns] t2 [ns] t3 [ns] 
RuSav0–aMV+ · Biot-TAA+ 25 (71%) 287 (21%) 2375 (8%) 
RuSav1–aMV+ · Biot-TAA+ 20 (62%) 261 (25%) 2380 (13%) 
RuSav2–aMV+ · Biot-TAA+ 20 (58%) 225 (25%) 1766 (17%) 
RuSav3–aMV+ · Biot-TAA+ 23 (60%) 274 (26%) 3120 (14%) 
 
Thus, in order to detect the TAA+ / MV+ photoproducts resulting from complete electron 
transfer as cleanly as possible, transient absorption spectra were generally recorded with a long delay 
time (10 µs) using long integration times (4 µs). After 10 µ s, unreacted 3MLCT excited states have 
decayed through common radiative and non-radiative pathways and do no longer contribute to the 
transient difference spectra, and simple [Ru(diimine)3]+ to TAA+ pairs have either recombined or 
undergone onward reaction to the desired TAA+ / MV+ products. Unfortunately, this leads to low 
signal to noise ratios (Figure 5.4). 
Once the TAA+ / MV+ pairs have been formed, this charge-separated state decays on a 
microsecond time scale. The respective transient absorption data monitoring the decay of TAA+ at 
750 nm (Figure C.21) and the decay of MV+ at 400 nm (Figure C.24) can be fitted in bi-exponential 
fashion for all four RuSavn–aMV2+ · Biot-TAA systems, with one time constant in the range of 225-
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287 ns and a second time constant between 1766 and 3120 ns (Table 5.1).  
The tethered triads RuSavn–aMV2+ · Biot-TAA, whereby the MV2+ is covalently linked to 
RuSav, affords instantly after photoexcitation an electron transfer to afford the corresponding TAA+ / 
MV+ (Figure C.24) in a subset of scaffolds. The charge separate state for the untethered triad on the 
other hand only builds over time (Figure C.25). In this case, MV2+ reduction is likely occurring from 
the long-lived 3MLCT excited-state via a diffusion controlled oxidative quenching pathway. 
In control experiments, we found that Biot-TAA is of key importance for the successful 
photo-generation of TAA+ / MV+ pairs. When instead TAA-NH2 is used (i. e., a triarylamine 
compound lacking the biotin unit, Figure 5.1), no TAA+ is formed (FigureC.S27). Conversely, 
covalent attachment of MV2+ was not essential for a photoproduct to form eventually, as long as a 
negative patch is engineered through point mutations in the proximity of the biotin-binding vestibule. 
Specifically, in the RuSavn systems with n = 1 – 3, MV+ formation is readily observable in presence of 
only 1 equivalent of ordinary (untethered) MV2+ (Figure C.28).  
This nicely illustrates the effectiveness of the engineered negative patch in attracting a cationic 
electron acceptor. In the RuSavn system with n = 0, i. e., the native Ru(II)-bioconjugated protein 
without negative patch, 15 equivalents of untethered MV2+ must be added in order to photo-generate 
a comparable amount of MV+ as in the RuSavn mutants with n = 1 – 3 in presence of only 1 equivalent 
of MV2+ (Figure C.29). This again illustrates the effectiveness of the negative patch in triggering 
charge transfer.  
Consequently, when adding 1 equivalent of Biot-TAA to the RuSavn systems with n = 1 – 3, 
addition of one equivalent of untethered MV2+ is sufficient for the photo-production of long-lived 
TAA+ / MV+ pairs (Figure C.30) similar to what was observed above for the RuSavn–aMV2+ · Biot-
TAA systems in which MV2+ was covalently tethered (Figure 5.4).Yet the combination of tethering 
the MV2+-moiety and implementing the negative patch is crucial to enable instant electron transfer 
within the triad. When methyl viologen is added in solution and a negative patch (RuSav3) is present, 
the temporal evolution of the transient absorption spectrum at 400 nm shows that the MV+ signal 
builds up rather slowly over time (Figure 5.5a). In contrast when no negative patch is present and the 
methyl viologen is tethered (RuSav0–aMV2+) a signal is instantly observable (Figure 5.5b). In the 
optimized system (RuSav3–aMV2+) where the methyl viologen is tethered and a negative patch is 
present, however, the signal intensity of the instantly appearing signal at 400 nm is more intense 
(Figure 5.5c). This highlights that a combination of tethering an oxidant and engineering a negative 
patch to increase the local concentration facilitates electron transfer on a protein scaffold. 
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Figure 5.5: Temporal evolution of the transient absorption signal at 400 nm of (a) RuSav3 · Biot-TAA with 1 equivalent 
of MV2+ in solution (b) RuSav0–aMV2+ · Biot-TAA and (c) RuSav3–aMV2+ · Biot-TAA (black traces correspond to the 
recorded data and red traces represent the fitted functions). 
 
5.4 Summary and Conclusions 
Streptavidin was used as a scaffold for donor-photosensitizer-acceptor triad assemblies that 
lead to the formation of long-lived charge-separated states after photoexcitation in the visible spectral 
range. This is more commonly achieved in rigid rod-like compounds requiring multi-step syntheses 
and tedious purification procedures.[292] Our study highlights that streptavidin can serve as a platform 
for the straightforward assembly of suitable donors, photosensitizers, and acceptors. The effectiveness 
of the biotin anchor group for anchoring of a triarylamine donor is no surprise given its known affinity 
for (strept)avidin, but the influence of the genetically engineered negative patch for binding of the 
cationic methyl viologen acceptor, as well at the covalent attachment of the electron acceptor onto the 
protein is remarkable. Exploitation of this electrostatic effect could become a general design principle 
for attachment of artificial redox cofactors or small-molecule catalysts to enzymes. Furthermore, with 
these anionic patches, addition of 1 equivalent of untethered methyl viologen is nearly as effective as 
addition of 15 equivalents of methyl viologen to Ru(II)-modified streptavidin without any negative 
patch. At present, the quantum yield for formation of electron transfer photoproducts is low, but this 
could potentially be improved by optimizing the driving-forces for the individual (energy-storing) 
electron transfer steps through donor, sensitizer, and acceptor variation.  
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6.1 Abstract 
Photocatalytic hydrogen evolution by an artificial hydrogenase basted on the biotin-streptavidin 
technology is reported. A biotinylated cobalt pentapyridyl-based water reducing catalyst (WRC) was 
incorporated into different mutants of streptavidin. Catalysis with [Ru(bpy)3]Cl2 as a photosensitizer 
(PS) and ascorbate as sacrificial electron donor (SED) at different pH values highlighted the impact 
of close lying amino acids that may act as a proton relay under the reaction conditions (Asp, Arg, Lys). 
In the presence of a close-lying lysine residue, both the turnover numbers were improved and the lag-
phase of the catalyst was reduced by up to 50%. The X-ray crystal structure of the artificial hydrogenase 
reveals a distance of 8.8 Å between the closest lying Co-moieties, we suggest that the hydrogen 
evolution mechanism is catalyzed via a single Co centre. Our findings highlight that streptavidin is a 
versatile host protein for the assembly of artificial hydrogenases and their activity can be fine-tuned 
via mutagenesis.  
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6.2 Introduction 
Splitting water into O2 and H2 using sunlight as energy source offers an attractive means to address 
the World’s growing energy needs.[334–337] Clean energies including solar, tidal, wind- or hydroelectric-
power plants are widely used, but generate electricity which is challenging to store. Storing the energy 
within chemical bonds and producing an energy carrier that can be liquefied or transported as a gas is 
desirable. There are multiple ways of producing hydrogen on an industrial scale, yet most of them rely 
on carbon sources, precious metal catalysts and are not energy efficient.[16,29,30] Hydrogenases are 
natural enzymes found in a variety of bacterial and archaeal organisms, where they generate reducing 
equivalents in the form of H2 or oxidize H2 in reactions that require a reductant.[92] Such enzymes 
display exquisite catalytic properties as they operate: i) without the need of a high overpotential, ii) at 
high reaction rates (1,500 – 20,000 turnovers per second (TOF), iii) under physiological conditions 
pH 7 and 37°C in water. To achieve such unrivalled characteristics, hydrogenases are highly evolved: 
specialized channels to deliver the substrates and extract the product: proton-, electron- and 
dihydrogen channels ensure that the reaction does not lead to the generation of side-products.[338] 
Importantly, natural hydrogenases rely on earth-abundant metals (i.e. Ni and Fe), but require complex 
maturation machineries to assemble and display modest stabilities under non-physiological 
conditions. Their oxygen sensitivity and production costs call for the development of artificial 
hydrogenases. Several artificial hydrogenases relying on the incorporation of artificial metal cofactors 
in host proteins (cytochrome c, rubredoxin, ferredoxin) or linking to a polypeptide.[201,208,291,339–343] In 
the past decade, the biotin-streptavidin technology has found widespread use for the assembly of 
artificial metalloenzymes (ArM).[156,159,160,239,344–346] Streptavidin (Sav) is a remarkably stable and 
versatile homotetrameric protein (4 x 159 amino acids, ca. 65 kDa). Each of the four monomers can 
bind one equivalent of biotin with a supramolecular binding affinity of ca. 1013 M-1, thus representing 
one of the strongest non-covalent interactions in nature. This feature offers the possibility to anchor 
abiotic cofactors within a protein environment to create artificial metalloenzymes. ArMs based on the 
biotin-Sav technology have been developed to catalyze a wide variety of water compatible reactions 
including: olefin metathesis, Suzuki-coupling, C–H activation or transfer hydrogenation 
etc.[159,185,191,195,347] Herein we report on our efforts to engineer an artificial hydrogenase based on the 
biotin-streptavidin technology. In view of the versatility of homogeneous Co-based hydrogen-
evolution catalysts, we selected this base metal for the development of ArMs, using [Ru(bpy)3]Cl2 as 
photosensitizer and ascorbate as reducing agent.  
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6.3 Results and Discussion 
6.3.1 Synthesis and binding studies 
The pentapyridine (appy) ligand and the corresponding Co-catalyst [CoBr(appy)-OH]Br was 
selected for derivatization with a biotin anchor, Scheme 6.1.[145] The biotinylated water reduction 
catalyst (WRC) [CoBr(appy)-Biot]Br was synthesized in 6-steps from commercial compounds, 
(Scheme 6.1, Figures C.1-C.6, see Appendix D for details). The hydroxyl-bearing pentapyridine 
(appy)-OH (1) was reacted with 1-iodo-3-azido-propane (2) to afford the corresponding azido ether 
(appy)-N3 (3). The azide group was reduced and the resulting amine (appy)-NH2 (4) was coupled 
to activated biotin-pentafluorophenylester 5 to afford the biotinylated ligand (appy)-Biot (6). 
Reaction with CoBr2 in MeOH yielded [CoBr(appy)-Biot]Br as a light brown solid which was 
purified by recrystallization. 
 
 
Scheme 6.1: Synthetic pathway of the water reduction catalyst [CoBr(appy)-OH]Br and its biotinylated counterpart 
[CoBr(appy)-Biot]Br (biotin depicted in blue, see the Appendix D for details). 
 
The affinity of [CoBr(appy)-Biot]Br towards streptavidin was evaluated relying on a 
displacement titration using 2-(4-hydroxyphenylazo)benzoic acid (HABA).[237,242] The titration 
revealed that all four biotin-binding sites of the homotetrameric Sav could accommodate one 
biotinylated cofactor [CoBr(appy)-Biot]Br (Figure D.7). The linear segment profile of the 
displacement titration highlight that the affinity of [CoBr(appy)-Biot]Br for Sav WT is comparable 
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to that of biotin itself (i.e. > 1010 M-1). This demonstrates that up to four equivalents of the bulky 
[CoBr(appy)-Biot]Br cofactor can bind quantitatively to the homotetrameric Sav host.  
 
6.3.2 Photocatalysis and genetic optimization 
To compare the activity of the Co-precursor [CoBr(appy)-OH]Br and its biotinylated 
analogue [CoBr(appy)-Biot]Br, argon-flushed, buffered (pH = 5) aqueous solutions were charged 
with 5 µM catalyst concentration, 1 M AscOH (sacrificial electron donor), 100 µM [Ru(bpy)3]Cl2 
(photosensitizer) and were irradiated with a LED (453 nm and 1100 Lux). Hydrogen evolution was 
continuously monitored by an automated GC as described elsewhere.[348] With no Sav present, both 
[CoBr(appy)-Biot]Br and [CoBr(appy)-OH]Br display similar turnover numbers after 6.5 hours 
(TON = 1051 and TON = 1120 after 6 hours, black and blue traces for [CoBr(appy)-Biot]Br and 
[CoBr(appy)-OH]Br respectively, Figure 6.1a). Addition of Sav WT (10 µM free biotin binding 
sites, corresponding to 2.5 µM tetrameric Sav) did not impact on the activity of [CoBr(appy)-
OH]Br, highlighting that there are no detrimental, non-specific interactions between the cofactor and 
Sav (grey trace, Figure 6.1a). In contrast, the biotinylated WRC displayed a marked decrease in 
activity (TON = 818 after 6 hours) highlighting the importance of second coordination sphere 
interactions on hydrogenase activity (green trace, Figure 6.1a). Next, we set out to explore the impact 
of the second coordination sphere of Sav. For this purpose, a focused library of Sav single point 
mutants was screened in combination with [CoBr(appy)-OH]Br. Building on previous studies, two 
close lying positions were selected: S112 and K121. Substitution of the serine residue S112 by either 
an Asp (Sav S112D, TON = 921 after 6 hours, light green trace, Figure 6.1b) or a Arg (Sav S112R, 
TON = 968 after 6 hours, turquoise trace, Figure 6.1b) lead to an increase in TON compared to Sav 
WT (green trace, Figure 6.1b). We speculate that this might be due to the presence of close lying 
amino acids capable of acting as a proton relay, potentially facilitating outer-sphere protonation of the 
Co-H species, as suggested in related studies.[148,158,349–353] This was confirmed by the improved activity 
of the S112K mutant which displays the highest activity (TON = 1069 after 6 hours, red trace, Figure 
6.1b). To further investigate the critical role of acidic residues in the proximity of the Co–H moiety, 
the double mutant Sav S121AK121A, where the naturally occurring lysine at position K121 was 
mutated to an alanine, displays a marked decrease in activity (TON = 526, after 4.5 hours, yellow trace, 
Figure 6.1b). The Sav K121W shows an even higher erosion in activity (TON = 396 after 4.5 hours, 
orange trace, Figure 6.1b).  
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Figure 6.1: Summary of turnover numbers and rates of artificial hydrogenases based on the biotin-streptavidin 
technology. (a) hydrogen production profile of the parent and the biotinylated complex with and without Sav: 
[CoBr(appy)-OH]Br (black trace), [CoBr(appy)-OH]Br with Sav WT (grey trace), [CoBr(appy)-Biot]Br (blue 
trace) and [CoBr(appy)-OH]Br with Sav WT (green trace), (b) genetic optimization of the hydrogenase activity for 
[CoBr(appy)-Biot]Br in the presence of a variety of Sav mutants: no protein (blue trace), Sav WT (green trace), Sav 
S112D (light green trace) Sav S112R (turquoise trace), Sav S112K (red trace), Sav S112AK121A (yellow trace) and Sav 
K121W (orange trace), (c) Turnover frequencies of selected hydrogenases: [CoBr(appy)-OH]Br (black trace), 
[CoBr(appy)-Biot]Br (blue trace) with Sav WT (green trace), Sav K121W (orange trace) and Sav S112K (red trace). 
Experiments were performed using 5 µM WRC, 1 M ascorbate buffer (pH 5) and 100 µM [Ru(bpy)3]Cl2 and 10 µM free 
biotin binding sites (when Sav was present). See SI for details, irradiation  
 
The reaction rates are also affected by incorporation of the cofactor into the protein. While 
the bare biotinylated cofactor [CoBr(appy)-Biot]Br has a maximum rate of 9 nmol H2/s (blue 
triangles, Figure 6.1c), the non-biotinylated WRC [CoBr(appy)-OH]Br peaks at 13 nmol H2/s 
(black squares, Figure 6.1c) and the incorporated cofactor [CoBr(appy)-Biot]Br · Sav S112K peaks 
at 12 nmol H2/s (red triangles, Figure 6.1c). The presence of cationic residues in the immediate 
proximity of the {Co(appy)}-moiety affects both the TON and the corresponding the rates. The 
effect of the additional lysine is highlighted by the use of SavWT (green triangles, Figure 6.1c) and the 
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worst performing mutant K121W (orange squares, Figure 6.1c). In fact, since the binding pocket is 
symmetrical, not only two lysines are present within the binding pocket (S112K and K121) but four 
(2xS112K and 2xK121, Figure 6.5). 
 
6.3.3 pH Dependence 
Hydrogen evolution at neutral pH is desirable, since safety concerns of off-site hydrogen 
production can be overcome and the corrosion of materials can be prevented.[354] Furthermore, if a 
catalyst is active at a physiological pH an in vivo application may be possible.  
Since the protein now provides a second coordination sphere around the catalytic centre and 
that lysines which lie in the close proximity of the cofactor were shown to have a positive effect on 
catalytic performance, we anticipated that the pH may influence catalysis. A pH screening of 
[CoBr(appy)-OH]Br, [CoBr(appy)-Biot]Br and [CoBr(appy)-Biot]Br · Sav S112K was 
performed (Figures D.8-D.14 and Tables D.1 and D.2). At pH 4 and pH 5 in 1 M AscOH buffer, 
[CoBr(appy)-OH]Br shows higher maximal rates than the biotinylated WRC [CoBr(appy)-
Biot]Br either inside or outside the Sav S112K (Figure 6.2). Increasing the pH above 5.0, leads to an 
inversion in trend: at pH 5.7 (using 1 M acetate buffer with 0.1 M AscOH) the [CoBr(appy)-Biot]Br 
· Sav S112K displays the highest rates and turnover numbers. At pH values between 6 and 7.5 (using 
a 1 M phosphate buffer, with 0.1 M AscOH) the dihydrogen production rates follow the following 
order: [CoBr(appy)-Biot]Br · Sav S112K > [CoBr(appy)-Biot]Br ≈ [CoBr(appy)-OH]Br 
(Figure 6.2). 
 
 
Figure 6.2: Maximum dihydrogen production rates determined as a function of pH for [CoBr(appy)-OH]Br (black 
squares) and [CoBr(appy)-Biot]Br · Sav S112K (red triangles), [CoBr(appy)-Biot]Br · Sav WT (green triangles), 
[CoBr(appy)-Biot]Br · Sav K121W (orange squares) and [CoBr(appy)-Biot]Br (blue triangle). The pH values were 
screened in buffered aqueous solutions (see Appendix D for details). 
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Incorporation of the biotinylated cofactor [CoBr(appy)-Biot]Br within Sav S112K affects 
both the reaction rate, as well as the time required to reach its maximal rate (Figure 6.3). As pH = 7.5, 
[CoBr(appy)-Biot]Br · Sav S112K requires 500 minutes to reach its maximum rate, whereas 
[CoBr(appy)-OH]Br requires 1100 minutes to react maximal rate.  
 
 
 
Figure 6.3: Summary of times required to reach the maximum rate of dihydrogen production as a function of pH. 
[CoBr(appy)-OH]Br (red squares), [CoBr(appy)-Biot]Br · Sav S112K (black triangle) and [CoBr(appy)-Biot]Br 
(blue triangle). 
 
Upon monitoring both the rate and TON at pH = 7.0 reveals that [CoBr(appy)-Biot]Br · 
Sav S112K outperforms both [CoBr(appy)-OH]Br and [CoBr(appy)-Biot]Br, Figure 6.4. The 
most striking difference is the smaller latent/incubation time required until the onset of catalytic 
activity. Although such incubation times are often observed with small molecule hydrogen evolution 
catalysts, their origin and cause remains an unsolved puzzle.[349,355–357] 
To rule out the possibility of spurious Co(II) species acting as catalyst, control experiments 
were conducted whereby some of the catalyst’s ingredients were omitted (Figure D.15). Compared 
to [CoBr(appy)-OH]Br · Sav S112K, under otherwise identical reaction conditions, Ru(bpy)32+ 
alone, Sav S112K, CoBr2 or CoBr2 · Sav S112K yielded only traces of dihydrogen. These observations 
suggest that the pentapyridine-coordinated Co(II) is indeed the species that generates the Co–H 
moiety, critical to the production of dihydrogen.  
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Figure 6.4: Comparison of the hydrogen production rate (left scale) and TON (right scale) for [CoBr(appy)-OH]Br 
(black trace), [CoBr(appy)-Biot]Br (blue trace) and [CoBr(appy)-OH]Br · Sav S112K (red trace) upon irradiation at 
453 nm with 100 µM [Ru(bpy)3]Cl2 in 1 M NaHPO4 buffer and 0.1 M AscOH present (See Appendix D for details). 
 
6.3.4 Structural Insight 
The localization of CoBr(appy)-Biot]Br within streptavidin was scrutinized by X-ray 
crystallography. A crystal of complex [CoBr(appy)-Biot]Br × Sav-K121A was obtained upon soaking 
apoprotein crystals with an excess of cofactor overnight. The X-ray structure of [CoBr(appy)-
Biot]Br · Sav S112A was solved to 1.7 Å resolution (Figures 6.5 and D.16).  
Upon solving the protein structure by molecular replacement residual electron density was 
visible in the biotin binding pocket. Complex [CoH2O(appy)-Biot]2+ was modelled in each of the 
four Sav monomers with full occupancy and in a single conformation. The first coordination sphere 
around cobalt is virtually identical to that found in the corresponding small molecule crystal structure 
(CCDC identifier: LILYAI).[145] The central metal is coordinated by the heteroaromatic groups in a 
distorted octahedral fashion. Axial bromide was replaced by water in the metalloenzyme. The bulky 
cobalt complex is accommodated within the biotin vestibule that is flanked from three side by loops 
3,4; 5,6 and 7,8, the fourth site occupying a symmetry-related cofactor molecule. The axial water 
ligand is exposed to the solvent and is presumed to be the substrate binding site. The distance between 
two neighbouring Co-atoms is 8.8 Å. Considering the large distance between the catalytically 
competent metals, we can exclude a catalytic mechanism that would proceed via a bimetallic 
mechanism. This hypothesis is further supported by the fact that, under typical reaction conditions, 
only half of the biotin binding sites are occupied with [CoBr(appy)-Biot]Br, albeit with a statistical 
distribution.[179] Of the two postulated mechanisms put forward for Co-based hydrogenase 
mimics,[349,358,359] we suggest that the present system operates using a single Co-site. This is consistent 
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with the proposal by Fukuzumi and co-workers,[359] whereby a {Co(III)–H}-moiety is protonated to 
afford dihydrogen. 
 
 
Figure 6.5: Close-up view of the active site in the crystal structure of complex [CoH2O(appy)-Biot] × Sav-K121A. The 
protein is displayed as surface and cartoon model and the cofactor as stick model. The cofactor is contoured by a 2Fo-Fc 
electron density map (1.0 s, blue colour) and an anomalous dispersion density map (3.0 s, green colour). The orange 
sphere indicates a cobalt and the magenta stick a water molecule. For clarity only one cofactor molecule is displayed per 
Sav tetramer. 
 
6.4 Conclusion and Outlook 
In conclusion, we have demonstrated that incorporation of a biotinylated, molecular water 
reduction catalyst into streptavidin as a protein scaffold effects its activity in a positive way. The 
catalyst inside the protein not only showed higher turn overs at specific pH values but also higher 
maximum rates and a shorter period of reaching them in almost all cases. The genetically engineered 
additional basic amino acid S112K close to the catalyst is beneficial for the activity. We suggest that 
this close lying pendant base is protonated under the reaction conditions and can thus facilitate 
protonation of the Co–H species. This hypothesis is further supported by deletion of all close-lying 
lysine residues. Accordingly, S112AK121A and K121W derived hydrogenases display significantly 
reduced activities. 
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Furthermore, the incorporation of the catalyst into a protein cavity prevented two Co-centres 
to interact with another. Since the bound catalyst showed similar or in some cases better activity than 
the free catalyst, we suggest that the reaction mechanism proceeds via a single Co-center.  
These findings suggest that such biohybrid catalysts may readily be optimized by genetic means. 
Future studies will focus on applying directed evolution optimization schemes to improve the 
hydrogenase activity. Finally, we hypothesize that the host protein may be immobilized on an 
electrode without perturbing the immediate environment around the metal cofactor. 
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The full Supporting Information can be found in the Appendix D. 
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7 Conclusion and Outlook 
This thesis describes the efforts undertaken of assembling an artificial hydrogenase for 
photocatalytic hydrogen evolution from aqueous solutions at biological relevant conditions. Different 
aspects of a biocompatible hydrogen production system were examined. 
First the hydrogen evolution activity of twelve different piano-stool complexes was tested. As 
hydrogen source served an aqueous solution of dilute formic acid which is split into one molecule of 
hydrogen and one molecule of carbon dioxide (Chapter 3). The catalysts 
[Cp*Ir(phenpzCO2H)H2O]+ 8 and [Cp*Ir(imim)H2O]2+ 11 could be identified to perform very 
well, yielding up to >3650 TON and >8700 TON respectively. They furthermore displayed good 
oxygen tolerance and recyclability, what is important for industrial applications and potential in vivo 
systems  
Next, the electron transfer on the surface of streptavidin was explored (Chapter 4). Four 
different streptavidin mutants were selected to study the rapid photo-triggered electron transfer from 
a biotinylated triarylamine to a ruthenium photosensitizer which was covalently attached to differently 
positioned cysteine residues. We could show that electron transfer occurred best, when the 
photosensitizer was attached to the K121C residue of streptavidin. This residue lies within the binding 
pocket and is thus in close proximity to an incorporated electron donor. This is an important finding 
in view of future photo-redox catalysis. This could make use of catalysts which are embedded in the 
protected environment of a biotin binding pocket of streptavidin and photosensitizers which are 
bound to the surface of streptavidin. In the case of this dyad the electron acceptor methylviologen was 
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added in high excess in solution. In a next step the electron acceptor was also covalently attached to 
the protein (Chapter 5). We chose to bind a methylviologen moiety to the N-terminus of the protein. 
The donor-photosensitizer-acceptor triad assembly lead to the formation of long-lived charge-
separated states after photoexcitation in the visible spectral range. This is more commonly achieved 
in rigid rod-like compounds requiring multi-step syntheses and tedious purification procedures. This 
highlights that streptavidin can serve as a platform for the straightforward assembly of suitable donors, 
photosensitizers, and acceptors. Furthermore, we genetically implemented a negative patch consisting 
of three negatively charged amino acid residues to the protein. The patch was engineered to be in close 
proximity to the biotin binding pocket to exploit its electrostatic effect onto the cationic electron 
acceptor methylviologen. With the anionic patch, addition of 1 equivalent of untethered methyl 
viologen is nearly as effective as addition of 15 equivalents of methyl viologen to Ru(II)-modified 
streptavidin without any negative patch. This could become a general design principle for the 
attachment of artificial redox cofactors or small-molecule catalysts to enzymes.  
This issue was addressed next, when a small molecule hydrogenase mimic was incorporated 
into streptavidin as a protein scaffold (Chapter 6). Depending on the explored mutants of streptavidin, 
higher turnover numbers and rates, as well as shorter lag-times were achieved. A genetically 
engineered additional lysine at position S112 close to the catalyst is beneficial for their activity since 
this pendant base is protonated under the tested conditions and can donate a proton. Pendant bases 
were already described to have a beneficial influence on hydrogen reduction and oxidation before, and 
we could support these findings. Interestingly, when the native lysine K121 was mutated to a 
tryptophan or alanine the reactivity dropped drastically. These findings show that these small 
molecule-protein agglomerates might be of great use in the future, since the protein provides a 
straightforwardly mutatable second coordination sphere, which is only hard to achieve by chemical 
means. Furthermore, the incorporation of the catalyst into the protein cavity prevented the two Co-
centres to interact with another. The bound catalysts showed similar or in some cases better activity 
than the free catalyst in solution. This leads to the assumption that the proposed heterogeneous 
reaction mechanism, involving the reduction from Co(III)-H to Co(II)-H by another Co(I) seems 
unfeasible, at least in our system.  
In the future, the combination of all tested approaches should be tested. For example, having 
the photosensitizer attached in close proximity to the protein binding could facilitate faster electron 
transfer from the photosensitizer to an incorporated catalyst. Furthermore, other photosensitizers, 
electron acceptors or electron donors can be assembled on the protein surface, eventually leading to 
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electron relays or proton or hydrogen channels, as found in natural hydrogenases. Other water 
reduction or water oxidation catalysts can be bound to biotin and brought into the binding pocket of 
streptavidin, since a beneficial effect of the assembly was found.  
Also, different sacrificial electron donors should be tested and maybe the negative patch can 
improve their reactivity towards a bound photosensitizer. The assembled hydrogenase could further 
be immobilized on electrodes what would make recycling of the system possible.  
Further mutagenesis of the protein, and utilization of two or more mutations simultaneously 
could eventually also add some of the features of real hydrogenase enzymes. Another approach would 
be the use of other enzymes (i.e. human carbonic anhydrase) with a different co-factor could yield in 
a higher activity. 
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A.1 General Methods 
A.1.1 Solvents and reagents 
Materials and reagents were purchased at the highest commercially available grade and used without 
further purification. Solvents used for reactions correspond to the quality “puriss”.  
 
A.1.2 NMR Spectroscopy 
1H and 13C spectra were recorded (295 K) on Bruker Avance DRX-500 or DPX-400 MHz 
spectrometers. Solvents for NMR were obtained from Cambridge Isotope Laboratories, Inc. 
(Andover, MA, USA). Chemical shifts (δ) are reported in ppm using trimethylsilyane or the residual 
solvent peaks as a reference and coupling constants (J) are reported in Hertz (Hz). 
The multiplicities are abbreviated as: s = singlet, d = doublet, t = triplet, m = multiplet and br= broad. 
 
A.1.3 Mass Spectroscopy 
High resolution mass spectrometry (HRMS) was recorded on a Bruker FTMS 4.7T 
BioAPEX II. The elemental analysis (EA) was measured on a Analysator 240 from Perkin-Elmer or a 
vario MICRO cube from Elementar. 
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A.1.4 Spectrophotometry 
Absorbance scans were recorded on a TECAN infinite M1000PRO. 
 
A.2 Synthesis 
Complexes 1[360], 2[361], 3[222], 4[362] (PF6), 5[363] (PF6), 7[364] (Cl), 8[365], 9[366] (Cl), 10[367] (PF6) and 
11[236] were synthesized according to literature procedures. 
NMR-Spectra of [Cp*Ir(phenpyCO2H)(H2O)]+ (6) 
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NMR-Spectra of [Cp*Rh(phenpzCO2H)(H2O)]+ (12)  
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A.3 Analytical Procedures 
A.3.1 Gas burette 
The gas evolution was monitored by an automated gas burette.[235] 
An acetic acid/sodium acetate buffer in water (2.0 ml of a 2.5 M stock solution) was charged 
with different concentrations of formic acid. The solution and the apparatus were degassed by 
sparging with N2 for 10 minutes. The reaction vessel was heated to 37°C and the system was allowed 
to equilibrate for 20 minutes and the catalyst, dissolved in degassed water (200 μl), was injected. The 
instrument was then set to record at a rate of 0.8 Hz. The burette operates by bubbling the evolved gas 
through a low-density mineral oil measuring the change of pressure by the evolved gas with a 
headspace manometer. 
For all further calculations, the composition of gas was assumed to be a 1:1 mixture of H2 and 
CO2 and the volume of 1 mole of gas was set to be 24.47 dm3 at room temperature.  
 
A.3.2 Total turnover Number 
An acetic acid/sodium acetate buffer (pH 4, 2.0 ml of a 2.5 M stock solution) in water was 
charged with 0.5 mmol formic acid yielding in a 0.23 M formic acid solution. The solution and the 
apparatus were degassed by sparging with N2 for 10 minutes. Afterwards, the reaction vessel was 
heated to 37°C and the system was allowed to equilibrate for 20 minutes. The catalyst (0.02 μmol 
dissolved in 200 μl degassed water) was injected yielding a final 9 μM catalyst concentration. After 
injection, the gas evolution was monitored. As soon as gas evolution ceased, an additional formate (0.5 
mmol) was added. This was repeated up to 3 times in 48 hours and resulted in the mentioned TTON. 
 
A.3.3 Air tolerance 
An acetic acid/sodium acetate buffer (pH 4, 2.0 ml of a 2.5 M stock solution) in water was 
charged with 0.5 mmol formic acid yielding in a 0.23 M formic acid solution. The solution and the 
apparatus were not degassed by sparging with N2 for 10 minutes.  
Three different experiments were conducted:  
 
i) Non-degassed solutions. No degassing was conducted. 
ii) Sparging the solution with air. The solution, the apparatus and the catalyst were sparged for 2 
minutes with air. 
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iii) Allowing the catalyst stand for 3 weeks on the lab bench in water under air. No degassing was 
conducted. 
 
The reaction vessel was heated to 37°C and the system was allowed to equilibrate for 20 
minutes. The catalyst (0.002 mmol dissolved in 200 μl water) was injected yielding a final 0.9 mM 
catalyst concentration. Following injection, the gas evolution was monitored. 
 
A.3.4 Dilution 
An acetic acid/sodium acetate buffer (pH 4, 2.0 ml of a 2.5 M stock solution) in water was 
charged with 0.5 mmol formic acid yielding in a 0.23 M formic acid solution. The solution and the 
apparatus were degased by sparging with N2 for 10 minutes. The reaction vessel was heated to 37°C 
and the system was allowed to equilibrate for 20 minutes. The catalyst (in 200 μl degassed water) was 
added to yield 45 μM, 23 μM and 2.3 μM final catalyst concentrations. After injection, the gas 
evolution was monitored.  
 
A.3.5 pH dependence 
An acetic acid/sodium acetate buffer (pH 4, 2.0 ml of a 2.5 M stock solution) in water with 
pH set to 4.0 or 5.0 or pure water was charged with 0.5 mmol formic acid yielding a 0.23 M formic acid 
solution. The solution and the apparatus sparged with N2 for 10 minutes. The reaction vessel was 
heated to 37°C and the system was allowed to equilibrate for 20 minutes. Then, the catalyst dissolved 
in degassed water (200 μl) was injected yielding a 0.9 mM catalyst concentration. After injection, the 
gas evolution was monitored.  
 
A.3.6 Calculations 
To calculate the conversion of formic acid, the detected gas volume was correlated to the 
SATP molar gas volume at 25°C. Taking in account that 1 mole of gas has the volume of 24.47 liter, 1 
mole of decomposed formic acid produces 48.94 liter of gas, since it is decomposed equally to H2 and 
CO2. Thus 0.1 mmol formic acid equals 4.94 ml of gas.  
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        Thus, for 2.1 ml gas collected after 30 minutes equals (2.1 ml / 24.47 ml/mmol) = 0.0858 mmol. 
Devided by two yields 0.0429 mmol, the amount of substance that has reacted. Taking in account that 
0.002 mmol catalyst was present a turnover number of 21 after 30 minutes can be determined. 
 
A.3.7 Kinetic Calculations 
The rate constants k and curves were calculated using OriginPro 9.0 by a first-order exponential fit 
function “ExpDec1”.  
 
 
Complex 3: 
  Value    Standard Error 
y0  0.00178 mol/l  1.89711E-5 mol/l 
A1  0.04436 mol/l  1.55676E-5 mol/l 
t1  6259.08607 s  6.11302 s 
k  1.59768E-4 s-1  1.56039E-7 s-1 
tau  4338.46786 s  4.23723 s 
 
Complex 7: 
  Value    Standard Error 
y0  -0.00147 mol/l  1.70508E-5 mol/l 
A1  0.04609 mol/l  1.52203E-5 mol/l 
t1  4638.20264 s  4.90027  s 
k  2.15601E-4 s-1  2.27783E-7 s-1 
tau  3214.95708 s  3.39661 s 
 
Complex 8: 
  Value    Standard Error 
y0  8.59619E-4 mol/l  5.92873E-6 mol/l 
A1  0.04746 mol/l  2.42519E-5 mol/l 
t1  1459.67529 s  1.28076 s 
k  6.85084E-4 s-1  6.0111E-7 s-1 
tau  1011.76981 s  0.88775 s 
01·1 )/exp( ytxAy +-=
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Complex 11 
  Value    Standard Error 
y0  9.70201E-4 mol/l  9.40838E-6 mol/l 
A1  0.04816 mol/l  2.91786E-5 mol/l 
t1  1892.23489 s  2.17028 s 
k  5.28476E-4 s-1  6.0613E-7 s-1 
tau  1311.59728 s  1.50432 s 
 
Since catalyst 9 deactivated in the course of the reaction, no accurate k value could be 
calculated. To estimate the rate constant, the dependence to the half time was used giving k = ln2/t1/2 
resulting in k = 8.68·10-4 s-1. 
 
A.3.8 CO detection 
A modified spottest from the literature was used to detect possible CO evolution.[368] 
A saturated aqueous solution of phosphomolybdic acid and a solution of 0.02 g PdCl2 in 10 
ml water were mixed in a 4:1 ratio. If CO is present a blue colour of molybdenum blue (Mo2O5) is 
detectable. A photospectrometer was used to measure the absorbance of the blue colour, if produced. 
For that purpose, different volumes of CO (10 µl, 20 µl, 50 µl and 100 µl) were injected to 200 µl of 
the mixed spot test solution. It was left sit for 1 h for the colour to build up. Then an absorbance scan 
measurement was conducted to determine the absorbance of the produced molybdenum blue (Figure 
S1, signal is increasing at around 760 nm). To measure whether the hydrogenases 8 and 11 also 
produced CO the evolved gas of the reaction with 0.23 M formate was passed through 200 µl of the 
spot test mixture. After the reaction was completed the absorbance was measured. Figure 2 shows that 
there is no difference between the reaction solution before and after the reaction. 
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Figure A.1: Absorbance scan of different CO concentrations 
 
Figure A.2: Absorbance scan of the detecting solution at start and after the reaction of 8 and 11 
 
A.3.9 NMR catalysis experiments 
NMR experiments were performed on a 600 MHz Bruker Avance III instrument with a 
BBFO+ smart probe in H2O / D2O (95 / 5 %) with or without acetic acid d-4 buffer (pH 4.0). 
Catalyst concentrations were 910 µM, while 45.5 mM of formate were applied. 1H NMR spectra 
were recorded using an excitation sculpting pulse sequence for water suppression.[369] 
500 600 700 800 900 1000
0.0
0.5
1.0
1.5
2.0
2.5
Ab
so
rb
an
ce
Wavelength (nm)
 10 µl
 20 µl
 50 µl
 100 µl
 0 µl
500 600 700 800 900 1000
0.0
0.2
0.4
0.6
0.8
1.0
Ab
so
rb
an
ce
Wavelength (nm)
 Start
 8
 11
  84 
 
Figure A.3: NMR reaction of [Cp*Ir(imim)(H2O)]+ (11) with 13C-labelled sodium formate at 298 K in H2O: 
a) before formate addition, b) after 75 min reaction time, c) after 1.5 days reaction time 
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A.4 TON determination 
 
Entry Catalyst Metal Ligand TON30[a] TON180[a] TON30[b] TON180[b] 
1 1 Ir H2O 1 2 1 4 
2 2 Ir bpy 0 2 1 3 
3 3 Ir bpy(OH)2 11 39 42 174 
4[c] 4 Ir phenpy 2 8 5 25 
5[c] 5 Ir phenpyOH 5 13 16 25 
6[c] 6 Ir phenpyCO2H 13 47 36 159 
7 7 Ir phenpz 18 47 64 181 
8 8 Ir phenpzCO2H 34 50 147 250 
9 9 Ir tosen 32 38 57 78 
10 10 Ir phenima 12 27 25 70 
11 11 Ir imim 29 50 91 250 
12 12 Rh phenpzCO2H 1 2 1 4 
13[d] – – – 0 0 0 0 
All experiments were conducted in 2.0 ml acetic acid/sodium acetate buffer (2.5 M, pH 4) containing the amount of 
tested substrate. That solution has been degassed for 10 minutes prior to the addition of catalyst by sparging with 
nitrogen gas. The temperature was set to 37 °C. After equilibration of the system 0.002 mmol catalyst dissolved in 0.2 
ml of degassed water was added and the measurement was started.  
[a] 0.1 mmol substrate, [b] 0.5 mmol substrate, [c] added 20% MeOH to the catalyst containing solution for better 
solubility, [d] 0.2 ml degased water without catalyst were added 
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B.1 Materials and Instruments 
Recombinant cysteine-containing streptavidin isoforms were engineered, expressed, purified 
and quantified as previously described.[270] Other reagents, substrates and materials were purchased 
from Sigma-Aldrich, TCI and Acros. MV2+ was added as methylviologene dichloride hydrate 
purchased from Sigma-Aldrich and used as is. UV−Vis experiments were conducted on a Varian 50 
Scan UV-Vis spectrophotometer. NMR experiments were performed on a Bruker Avance III NMR 
spectrometer operating at 400 MHz proton frequency and 101 MHz carbon frequency. Chemical 
shifts were referenced to residual d6-DMSO (2.50 ppm) for 1H spectra or d6-DMSO (39.52 ppm) for 
13C spectra. Signals are quoted as s (singlet), d (doublet), t (triplet) and m (multiplet). Flash column 
purification was performed on a Biotage Isolera One. Mass spectra were acquired on Bruker esquire 
3000 plus and Bruker maxis 4G QTOF EDI spectrometers. An LP920-KS instrument from Edinburgh 
Instruments was used for transient absorption spectroscopy. The frequency doubled output of a 
Quantel Brilliant b laser served as an excitation source. The laser pulse duration was 10 ns and the 
pulse frequency was 10 Hz. The typical pulse energy used for transient absorption studies was 15 mJ. 
Detection of transient absorption spectra occurred on an iCCD camera from Andor. All optical 
spectroscopic experiments were performed under aerated conditions in MilliQ water.  
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B.2 Synthesis 
The compounds TAA-NO2,[370] TAA-NH2,[371] [Ru(bpy)2(phenNH2)](PF6)2[372] and Biotin 
pentafluorophenyl ester[373] were synthesized as previously reported. 
 
 
Figure B.1: Synthesis of [Ru(bpy)2(phenNHCOCH2Br)](PF6)2 1: a) phenNH2, [Ru(bpy)2Cl2], MeOH, reflux, 
overnight b) [Ru(bpy)2(phenNH2)](PF6)2, BrCH2COBr, CH3CN, r.t., overnight. 
 
B.2.1 Synthesis if [Ru(bpy)2(phenNHCOCH2Br)](PF6)2 
Adapted from Fedorova et al.[374] Under N2, [Ru(bpy)2(phenNH2)](PF6)2 (30.0 mg, 0.033 
mmol) was dissolved in dry acetonitrile (2.0 ml). Bromoacetyl bromide (13.0 µl, 0.15 mmol) was 
added and the reaction mixture was stirred overnight at room temperature in the dark. The solvent 
was removed in vacuo and the residue was dissolved in a minimal amount of MeOH. A saturated 
aqueous solution of NH4PF6 was added and the precipitate was collected, washed with water followed 
by Et2O to yield the product as a red solid (0.027 mmol, 27.6 mg, 82%). 
 
1H (400MHz, d6-DMSO): 10.87 (s, 1H), 8.93-8.76 (m, 6H), 8.64 (s, 1H), 8.21 (tt, J = 7.9, 1.5 Hz, 
2H), 8.17 (dd, J = 5.3, 1.1 Hz, 1H), 8.11 (tdd, J = 7.8, 2.7, 1.5 Hz, 2H), 8.05 (dd, J = 5.2, 1.2 Hz, 1H), 
7.94 (dd, J = 8.6, 5.2 Hz, 1H), 7.87-7.79 (m, 3H), 7.62-7.54 (m, 4H), 7.35 (ddt, J = 7.4, 5.8, 1.5 Hz, 
2H), 4.34 (d, J = 1.3 Hz, 2H). 13C (101 MHZ, d6-DMSO): 166.5, 156.8, 156.55, 156.52, 152.48, 
151.5, 151.46, 147.24, 144.81, 137.97, 137.85, 136.47, 133.1, 132.28, 130.1, 127.84, 127.81, 127.74, 
126.59, 126.3, 125.9, 124.47, 124.38, 29.89. HRMS (ESI+) calcd. for C34H26BrN7ORu2+ 364.5207; 
found, 364.5213. 
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Figure B.2: 1H-NMR spectrum of 1 in d6-DMSO. 
 
 
Figure B.3: 13C-NMR spectrum of 1 in d6-DMSO. 
 
  
 
89 
 
Figure B.4: Synthesis of Biot-TAA 2 and TAA-Ac 3: a) p-fluoronitrobenzene, 4,4’-dimethoxydiphenylamine, NaH, 
DMAc, 100°C, 3 h b) H4N2, Pd/C, EtOH, 75°C, overnight. c) Biotin-PFP, TAA-NH2, DMF, r.t., overnight d) AcOCl, 
Et3N, TAA-NH2, DCM, r.t., overnight. 
 
B.2.2 Synthesis of Biot-TAA 
Biotin pentafluorophenyl ester (37.4 mg, 0.09 mmol) was dissolved in dry DMF (1.0 ml) 
under N2. TAA-NH2 (29.2 mg, 0.09 mmol), dissolved in dry DMF (1.0 ml), was added dropwise at 
0°C. After addition, the reaction mixture was stirred overnight at room temperature. Dry DCM (3.0 
ml) was added and the organic phase was washed with degassed H2O (3 x 10.0 ml). The combined 
organic phases were dried over Na2SO4 and the solvents were removed under reduced pressure. To 
remove residual DMF, the compound was dissolved in a minimal amount of dry DCM and 
precipitated with cold Et2O to yield the product as an off-white solid (0.06 mmol, 33.5 mg, 68%). 
 
1H (400 MHz, d6-DMSO): 9.79 (s, 1H), 7.40 (d, J = 9.0 Hz, 2H), 6.94-6.84 (m, 8H), 6.79 (d, J = 8.9 
Hz, 2H), 6.44 (s, 1H), 6.36 (s, 1H), 4.30 (ddt, J = 7.6, 5.1, 1.1 Hz, 1H), 4.13 (ddd, J = 7.8, 4.4, 1.8 Hz, 
1H), 3.72 (s, 6H), 3.12 (ddd, J = 8.5, 6.1, 4.4 Hz, 1H), 2.82 (dd, J = 12.4, 5.1 Hz, 1H), 2.58 (d, J = 12.5 
Hz, 1H), 2.26 (t, J = 7.3 Hz, 2H), 1.71-1.27 (m, 6H). 13C (101 MHZ, d6-DMSO): 170.66, 162.68, 
154.99, 143.54, 140.84, 133.24, 125.27, 121.85, 120.31, 114.79, 61.03, 59.18, 55.40, 55.21, 39,85, 
36.10, 28.23, 28.09, 25.22. HRMS (ESI+) calcd. for C30H34N4O4S+ 546.2301; found, 546.2296. 
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Figure B.5: 1H-NMR spectrum of 2 in d6-DMSO. 
 
 
 
Figure B.6: 13C-NMR spectrum of 2 in d6-DMSO. 
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B.2.3 Synthesis of TAA-Ac 
A solution containing of TAA-NH2 (89.0 mg, 0.28 mmol) and Et3N (39 µl, 0.53 mmol) in dry 
DCM (4.0 ml) was added dropwise to a cooled solution of acetylchloride (20.0 µl, 0.28 mmol) in dry 
DCM (1.0 ml) at 0°C under an inert atmosphere. After addition, the reaction mixture and stirred 
overnight at room temperature. Dry diethyl ether (10.0 ml) was added and the reaction mixture was 
washed with NH4Cl sat. (2 x 10.0 ml) and brine (10.0 ml), dried over Na2SO4 and concentrated under 
reduced pressure. Further purification of the crude mixture by automated column chromatography 
(cyclohexane / EtOAc, 0%→50%) afforded the product as an off-white solid (0.14 mmol, 51 mg, 50%).  
 
1H (400 MHz, d6-DMSO): 9.75 (s, 1H), 7.42 (d, J = 8.9 Hz, 2H), 6.94-6.84 (m, 8H), 6.79 (d, J = 8.9 
Hz, 2H), 3.72 (s, 6H), 1.99 (s, 3H). 13C (101 MHz, d6-DMSO): 167.72, 155.01, 143.56, 140.82, 
133.23, 125.29, 121.75, 120.25, 114.79, 55.20, 23.80. HRMS (ESI+) calcd. for C22H22N2O3+ 362.1630; 
found, 362.1624. 
 
Figure B.7: 1H-NMR spectrum of 3 in d6-DMSO. 
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Figure B.8: 13C-NMR spectrum of 3 in d6-DMSO. 
 
B.3 Manipulation of the streptavidin mutants 
B.3.1 Bioconjugation of [Ru(bpy)2(phenNHCOCH2Br)](PF6)2 to the cysteine-
containing streptavidin mutants 
According to a modified protocol of Roelfes et al.[269] 
The Sav mutants (1.2 µmol) were dissolved in NaH2PO4 buffer (6.0 ml, 50 mM, pH 7.6) and 
[Ru(bpy)2(phenNHCOCH2Br)](PF6)2 1 (9.6 µmol, 9.8 mg) in 50 µl DMSO were added. The 
mixture was agitated in the dark at 4°C, 600 rpm for 24 h. The solution was then centrifuged and 
transferred to a Spectra/Por® 1 Dialysis Membrane Standard RC Tubing (MWCO: 6-8 kD) and 
dialyzed against MilliQ water in the dark for 5 days at 4°C, changing the water twice a day. After 5 days, 
the dialyzed water was colourless. The solution was filtered through a Filtropur S 0.2 µm and 
lyophilized for 2 days to yield a yellow fluorescent protein sample. 
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B.3.2 Mass Spectrometry of the Ru-Sav adducts 
 
Figure B.9: Mass spectrum of K121C-Ru modified Sav mutant. K121C unmodified mass: 16400 Da, expected for 
bioconjugated with Ru complex 17049 Da , found 17046 Da. 
 
 
 
Figure B.10: Mass spectrum of S112C-Ru modified Sav mutant. S112C unmodified mass: 16441 Da, expected for 
bioconjugated with Ru complex 17090 Da , found 17087 Da. 
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Figure B.11: Mass spectrum of R84C-Ru modified Sav mutant. R84C unmodified mass: 16372 Da, expected for 
bioconjugated with Ru complex 17021 Da , found 17017 Da. 
 
 
 
Figure B.12: Mass spectrum of T66C-Ru modified Sav mutant. T66C unmodified mass: 16427 Da, expected for 
bioconjugated with Ru complex 17076 Da , found 17074 Da. 
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B.4 Photoexcitation experiments 
 
Figure B.13: (a) Transient absorption spectra of S112C-Ru measured after excitation at 532 nm with laser pulses of ~10 
ns duration. The spectra were time-integrated over 200 ns immediately after excitation. Sample concentrations were: 5×10-
5 M Ru(II)-streptavidin, 120 mM MV2+, 2.5×10-5 M Biot-TAA or TAA-Ac, where applicable. The solvent was MilliQ water 
at 25 °C. (b) Temporal evolution of the transient absorption signal at 760 nm for 3 of the 4 samples from (a). 
 
 
Figure B.14: (a) Transient absorption spectra of R84C-Ru measured after excitation at 532 nm with laser pulses of ~10 
ns duration. The spectra were time-integrated over 200 ns immediately after excitation. Sample concentrations were: 5×10-
5 M Ru(II)-streptavidin, 120 mM MV2+, 2.5×10-5 M Biot-TAA or TAA-Ac, where applicable. The solvent was MilliQ water 
at 25 °C. (b) Temporal evolution of the transient absorption signal at 760 nm for 3 of the 4 samples from (a). 
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Figure B.15: (a) Transient absorption spectra of T66C-Ru measured after excitation at 532 nm with laser pulses of ~10 
ns duration. The spectra were time-integrated over 200 ns immediately after excitation. Sample concentrations were: 5×10-
5 M Ru(II)-streptavidin, 120 mM MV2+, 2.5×10-5 M Biot-TAA or TAA-Ac, where applicable. The solvent was MilliQ water 
at 25 °C. (b) Temporal evolution of the transient absorption signal at 760 nm for 3 of the 4 samples from (a). 
 
B.5 Distance estimations 
 
Figure B.16: Close-up view of the biotin binding vestibule bearing a single arylated biotin from pdb code: 3PK2. The 
distances were measured through space from the sulfur atom (yellow) of the cofactor (red) to the a-carbon atoms 
(yellow) of the amino acids of interest (here K121 displayed in orange). The iridium-Cp*-complex was omitted for clarity. 
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Figure B.17: Estimated through-space distances between the sulfur atom of a biotinylated cofactor (pdb code 3PK2) and 
the a-carbon atoms of the K121 residue of all four monomers of homotetrameric Sav. 
 
Figure B.18: Estimated through-space distances between the sulfur atom of a biotinylated cofactor (pdb code 3PK2) and 
the a-carbon atoms of the S112A residue of all four monomers of homotetrameric Sav. 
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Figure B.19: Estimated through-space distances between the sulfur atom of a biotinylated cofactor (pdb code 3PK2) and 
the a-carbon atoms of the R84 residue of all four monomers of homotetrameric Sav. 
 
 
Figure B.20. Estimated through-space distances between the sulfur atom of a biotinylated cofactor (pdb code 3PK2) and 
the a-carbon atoms of the T66 residue of all four monomers of homotetrameric Sav. 
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B.6 Biotin-binding site determination[187,242] 
The Sav mutants (76.8 nmol) were dissolved in NaH2PO4 buffer (2.4 ml, 20 mM, pH 7.0). The 
solutions were treated with a 2-(4-hydroxyphenylazo)benzoic acid (HABA) solution (300 µl, 9.6 
mM) in NaH2PO4 buffer (20 mM, pH 7.0) filled into a cuvette and left standing for 5 minutes. A blank 
of the buffer was measured at 506 nm in a Varian 50 Scan UV-Vis spectrophotometer. The resulting 
sample was analyzed and aliquots (5.0 µl) of a biotin (or Biot-TAA) solution (0.96 mM) in DMSO 
were added after each spectroscopic determination. The data points were plotted with Origin Pro 
9.0.0 to determine the number of biotin-binding sites and the stoichiometry for the Sav embedded 
dyads. 
 
 
 
Figure B.21: HABA displacement titrations of biotin (black symbols) and the biotinylated triarylamine Biot-TAA (red 
symbols) of a) S112-Ru b) R84C-Ru c) T66C-Ru.   
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C.1 Materials and Instruments 
Recombinant cysteine-containing streptavidin isoforms were engineered, expressed, purified 
and quantified as previously described.[270,375] Other reagents, substrates and materials were purchased 
from Sigma, Aldrich, TCI and Acros. MV2+ was added as methyl viologen dichloride hydrate 
purchased from Sigma-Aldrich and used as is. NMR experiments were performed on a Bruker Avance 
III NMR spectrometer operating at 400 MHz proton frequency and 101 MHz carbon frequency. 
Chemical shifts were referenced to residual d6-DMSO (2.50ppm) for 1H spectra or d6-DMSO (39.52 
ppm) for 13C spectra. Signals are quoted as s (singlet), d (doublet), t (triplet) and m (multiplet). Flash 
column purification was performed on a Biotage Isolera One. Mass spectra were acquired on Bruker 
Esquire 3000 plus and Bruker maxis 4GQTOF EDI spectrometers. An LP920-KS instrument from 
Edinburgh Instruments was used for transient absorption spectroscopy. The frequency-doubled 
output of a Quantel Brilliant b laser served as an excitation source. The laser pulse duration was 10 ns 
and the pulse frequency was 10 Hz. The typical pulse energy used for transient absorption studies was 
10 mJ. The excitation wavelength was 450 nm in all experiments and the number of averages used to 
record all of the presented spectra was 20. Detection of transient absorption spectra occurred on an 
iCCD camera from Andor and the spectra were time-integrated over 4 µs. The data is presented as 
raw data without artificial baseline and emission corrections. The experimental uncertainty of the 
lifetime measurements is +/- 10%. All optical spectroscopic experiments were performed under 
deaerated conditions in milliQ water. ESI+-MS spectra of proteins were recorded with a Waters SQ 
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Detector 2 on a Waters Acquity M-class UPLC (Acetonitrile / H2O, both with 0.1 % formic acid) with 
a Aeris Widefore column from phenomenex (3.6 µm, C4, 50 x 2.1 mm) and deconvoluted with the 
software MassLynx.  
 
C.2 Synthesis 
The compounds Biot-TAA,[322] TAA-NH2,[376] Ru(bpy)2(phenNH2COCH2Br)](PF6)2[377] and 
MeMV+I[378] were synthesized as previously reported, Scheme S1 
 
 
Scheme C.1: Synthesis of aMV2+: a) DBU, DCM, r.t., overnight, b) CH3CN, 75°C, overnight c) 2, MeOH, 4 M HCl in 
Dioxane, r.t., 1 h. 
 
C.2.1 Synthesis of BrCH2CHCHCH2ONHBoc 
To a solution of trans-1,4-dibromobut-2-ene (4.28 g, 20.0 mmol) and N-Boc-hydroxylamine 
(900 mg, 6.76 mmol) in dry DCM (10.0 ml) 1,8-Diazabicyclo[5.4.0]undec-7-en (DBU) (1.6 ml, 10.3 
mmol) was added at 0°C. It was left stirring in the dark overnight at room temperature. The solvent 
was then removed in vacuo and the crude reaction mixture was purified via automated flash column 
chromatography (10% EtOAc/Cyclohexane, Rf = 0.35). The product was obtained as a colourless oil 
(453 mg, 25%). 
 
1H (400 MHz, CDCl3): 7.11 (s, 1H), 6.04-5.86 (m, 2H), 4.36 (dd, J = 6.0, 0.9 Hz, 2H), 3.95 (dd, J = 
7.1, 0.7 Hz, 2H), 1.48 (s, 9H). 13C (101 MHz, CDCl3): 156.92, 131.57, 129.35, 82.08, 75.94, 31.54, 
28.35, HRMS (ESI+) calcd. for [M+Na+] C9H16BrNNaO3 288.0206; found 288.0206. 
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Figure C.1: 1H-NMR spectrum of 1 in CDCl3. 
 
Figure C.2: 13C-NMR spectrum of 1 in CDCl3. 
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Figure C.3: HRMS (ESI+) spectrum of 1; calcd. for [M+Na+] C9H16BrNNaO3 288.0206; found 288.0206, calcd. for 
[M+K+] C9H16BrNKO3 303.9945; found 303.9941; calcd. for [M-C4H8+Na+] C5H8BrNNaO3 231.9580; found 231.9580; 
calcd. for [M-C4H8+H+] C5H9BrNO3 209.9760; found 209.9759. 
 
C.2.2 Synthesis of MeMV2+-CH2CHCH2ONHBocI-Br- 
Under N2, BrONHBoc 1 (180 mg, 0.68 mmol) was added to a solution of MeMV+I- (100 mg, 
0.34 mmol) in dry acetonitrile (10.0 ml). The reaction mixture was heated to 75°C and stirred 
overnight. It was then left to cool to room temperature and centrifuged. The solid was dissolved in a 
minimal amount of MeOH. Then, Et2O was added to precipitate the product. After washing three 
times with Et2O, the salt was dried in vacuo to yield a light brown/orange solid (66 mg, 35%). 
 
1H (400 MHz, d6-DMSO): 10.08 (s, 1H), 9.35 (d, J = 7.0 Hz, 2H), 9.30 (d, J = 6.7 Hz, 2H), 8.81 (d, 
J = 6.9 Hz, 2H), 8.76 (d, J = 6.9 Hz, 2H), 6.17-6.01 (m, 2H), 5.38 (d, J = 5.6 Hz, 2H), 4.44 (s, 3H), 
4.27 (d, J = 4.5 Hz, 2H), 1.39 (s, 9H). 13C (101 MHz, d6-DMSO): 156.09, 148.94, 148.10, 146.63, 
145.77, 133.08, 126.73, 126.25, 126.16, 79.78, 74.38, 61.42, 48.04, 28.03. EA C20H27BrIN3O3: calcd. 
C 42.57, H 4.82, N 7.45; found C 42.92, H 5.11, N 7.96. 
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Figure C.4: 1H-NMR spectrum of 2 in d6-DMSO. 
 
Figure C.5: 13C-NMR spectrum of 2 in d6-DMSO. 
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C.2.3 Synthesis of MeMV2+-CH2CHCH2ONH3+I-Br-Cl- (aMV2+) 
The protected MeMV2+-CH2CHCHCH2ONHBoc 2 (30 mg, 53.2 µmol) was dissolved in 
MeOH (2.0 ml) and 4 M HCl in Dioxane (2.0 ml) was added. It was left stirring for 2 h at room 
temperature. The solvent was removed in vacuo and it was dissolved in a minimal amount of MeOH. 
The final product was precipitated and washed three times with Et2O. Yellow solid (23.3 mg, 88%). 
 
1H (400 MHz, d6-DMSO): 11.01 (bs, 3H), 9.43 (d, J = 6.9 Hz, 2H), 9.32 (d, J = 7.0 Hz, 2H), 8.83 (d, 
J = 7.0 Hz, 2H), 8.79 (d, J = 7.0 Hz, 2H), 6.27-6.00 (m, 2H), 5.43 (d, J = 6.2 Hz, 2H), 4.60 (d, J = 5.0 
Hz, 2H), 4.45 (s, 3H). 13C (101 MHz, d6-DMSO): 148.95, 148.12, 146.64, 146.01, 130.17, 129.10, 
126.66, 126.15, 72.89, 61.15, 48.00. EA C15H24BrClIN3O3: calcd. C 33.57, H 4.51, N 7.83; found C 
33.52, H 4.25, N 7.83. 
 
 
Figure C.6: 1H-NMR spectrum of aMV2+ in d6-DMSO. 
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Figure C.7: 13C-NMR spectrum of aMV2+ in d6-DMSO. 
 
C.3 Engineering a negative patch on the surface of Sav 
 
Figure C.8: Surface representation of S112A Sav highlighting its eight carboxylic amino acids, six of which are surface-
exposed. The naturally occurring Glu and Asp residues are highlighted (red) as well as biotin (blue, stick representation; 
note: the organometallic cofactor bound to the biotin moiety in this crystal structure was removed due to clarity). The 
negative patch was engineered around E51. D61 is not visible as it is buried between two dimers of the protein (red arrow) 
(pdb: 3PK2).[185] 
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Figure C.9: SDS PAGE of Sav mutants with an engineered negative patch. Ladder (lines 1, 5, 9), SavWT (2), K121C (3), 
N-flex Sav0 (K121C with a flexible N-terminus) (4), N-flex Sav1 (additional R84E mutation) (6), N-flex Sav2 (additional 
N82D-R84E mutation) (7) and N-flex Sav3 (additional N82D-Y83E-R84E mutation) (8) with (top) B4F-fluorescence 
staining and (bottom) Coomassie staining. 
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C.4 Bioconjugation of the MV2+ moiety at the N-terminus of the Sav mutants 
The bioconjugation of the cysteine-containing streptavidin mutants with 
[Ru(bpy)2(phenNHCOCH2Br)](PF6)2 (1) was performed as previously described.[322]  
The bioconjugation of the PS-containing mutants (RuSavn, where n = 0 – 3) was performed 
according to a modified protocol of Francis et al.[328] First the protein (0.6  mol) were dissolved in 300 
µl of phosphate buffer (pH 6.5, 20 mM). Then 300 µl of a PLP solution (pH 6.5, 0.2 M) was added 
and the combined solutions were agitated at 37°C for 1 h. Afterwards, the solution was filtered through 
a size exclusion centrifugation filter (10 kD cutoff) for 10 minutes at 14.8 G and washed with 
phosphate buffer until the eluate was colorless. The concentrated solution was then dissolved in buffer 
(total volume 150 µl). Then a aMV2+ solution (100 µl, pH 1.5, 60 mM, aMV2+ was dissolved in 50 µl 
Na2CO3 (sat. aq.) and the pH was subsequently adjusted to pH 1.5 with HCl) were added. The pH 
was adjusted to 2.2 with HCl (0.1 M) and it was agitated for 1.5 hours at 37°C. Then, the solution was 
diluted with phosphate buffer (pH 6.5, 20 mM to 6.0 ml and diafiltrated twice with a 10% NaCl 
solution and three times with milliQ water. After lyophilizing, the modified proteins (RuSavn-aMV2+, 
where n = 0 – 3) were obtained as a slight yellow powder. 
 
C.5 Mass spectra of the bioconjugated products 
 
Figure C.10: ESI+-MS spectrum of RuSav0: expected for bioconjugated with Ru(bpy)2(phenNH2COCH2Br)](PF6)2 
16733 Da; found 16728 Da. 
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Figure C.11: ESI+-MS spectrum of RuSav0—aMV2+: expected for bioconjugated with Ru(bpy)2 
(phenNH2COCH2Br)](PF6)2 and aMV2+ 16971 Da; found 16960 Da. 
 
 
Figure C.12: ESI+-MS spectrum of RuSav1: expected for bioconjugated with Ru(bpy)2(phenNH2COCH2Br)](PF6)2 
16706 Da; found 16700 Da. 
 
Figure C.13: ESI+-MS spectrum of RuSav1—aMV2+: expected for bioconjugated with Ru(bpy)2 
(phenNH2COCH2Br)](PF6)2 and aMV2+ 16944 Da; found 16932 Da. 
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Figure C.14: ESI+-MS spectrum of RuSav2: expected for bioconjugated with Ru(bpy)2(phenNH2COCH2Br)](PF6)2 
16705 Da; found 16700 Da. 
 
 
Figure C.15: ESI+-MS spectrum of RuSav2—aMV2+: expected for bioconjugated with Ru(bpy)2 
(phenNH2COCH2Br)](PF6)2 and aMV2+ 16945 Da; found 16934 Da. 
 
Figure C.16: ESI+-MS spectrum of RuSav3: expected for bioconjugated with Ru(bpy)2(phenNH2COCH2Br)](PF6)2 
16671 Da; found 16664 Da. 
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Figure C.17: ESI+-MS spectrum of RuSav3—aMV2+: expected for bioconjugated with Ru(bpy)2 
(phenNH2COCH2Br)](PF6)2 and aMV2+ 16909 Da; found 16900 Da. 
 
C.6 Estimation of the distances 
 
Figure C.18: Estimated through-space distances between the sulfur atom of a biotinylated cofactor (blue stick 
representation) and the a-carbon atoms of the K121 residues (yellow stick representation, here the position of the 
[Ru(diimine)3]2+ attachment) and the a-carbon atoms of the closest negatively charged amino acid R84E (red stick 
representation) of two monomers on the same face of homotetrameric Sav (These two monomers form the so-called 
biotin-binding vestibule that can accommodate up to two biotinylated probes). The naturally occurring negatively charged 
amino acid E51 is also highlighted (orange stick representation).[185] 
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Table C.1: Estimated through-space distances between a-carbon atoms of K121 and R84 positions and the sulfur atom 
of a biotinylated cofactor based on the crystal structure of streptavidin (pdb code: 3PK2). 
 aC-K121 N-Biot-TAA aC-R84 
aC-K121 - 7.1 Å / 8.6 Å 18.7 Å / 22.0 Å 
N-Biot-TAA 7.1 Å / 8.6 Å - 14.8 Å / 21.7 Å 
aC-R84 18.7 Å / 22.0 Å 14.8 Å / 21.7 Å - 
 
C.7 Biotin-binding activity determination[296,302] 
The Sav mutants (76.8 nmol) were dissolved in NaH2PO4 buffer (2.4 ml, 20 mM, pH 7.0). The 
solutions were treated with a 2-(4-hydroxyphenylazo)benzoic acid (HABA) solution (300 µl, 9.6 
mM) in NaH2PO4 buffer (20 mM, pH 7.0) filled into a cuvette and incubated for 5 minutes. A blank 
of the buffer was measured at 506 nm using a Varian50 Scan UV-Vis spectrophotometer. The 
absorbance of the resulting sample was determined and aliquots of a biotin (or Biot-TAA, 5.0 µl) 
solution (0.96 mM) in DMSO were added sequentially. The data points were plotted with Origin Pro 
9.0.0 to determine the number of biotin-binding sites and the number of Biot-TAA that can bind into 
the homotetrameric for the bioconjugated-Sav scaffolds. 
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Figure C.19: HABA-displacement titration of biotin (black symbols) and the biotinylated triarylamine Biot-TAA (red 
symbols) of a) RuSav0 b) RuSav1 c) RuSav2 and d) RuSav3. 
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Figure C.20: HABA-displacement titration of biotin (black symbols) and the biotinylated triarylamine Biot-TAA (red 
symbols) of a) RuSav0—aMV2+ b) RuSav1—aMV2+ c) RuSav2—aMV2+ and d) RuSav3—aMV2+. 
 
C.8 Photoexcitation experiments 
The proteins RuSavn or RuSavn—aMV2+ (where n = 0 - 3) were dissolved in 1.5 ml milliQ 
water (50 µM final concentration) in an inert gas cuvette. The solution was then degassed using the 
freeze-pump-thaw method. After three cycles, the cuvette was filled with an argon atmosphere. After 
addition of Biot-TAA, TAA-NH2 or MV2+, the cuvettes were again degassed using the same method. 
Stock solutions (7.5 µl) of the triarylamines Biot-TAA and TAA-NH2 as well as MV2+ were added to 
reach a final concentration of 50 µM. 
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Figure C.21: Temporal evolution of the transient absorption signal at 750 nm of (a) RuSav0—aMV2+, (b) RuSav1—
aMV2+, (c) RuSav2—aMV2+ and (d) RuSav3—aMV2+ with 1 equivalent of Biot-TAA (black traces) and the fitted 
functions (red traces). 
 
  
Figure C.22: Transient absorption spectra of 50 µM of RuSav0—aMV2+ (black trace), RuSav1—aMV2+ (blue trace), 
RuSav2—aMV2+ (green trace) and RuSav3—aMV2+ (red trace) in milliQ water at 25 °C, immediately after excitation at 
450 nm in presence of 50 µM Biot-TAA. 
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Figure C.23: Normalized luminescence decay detected at 630 nm following excitation of RuSav0 (orange trace) and 
RuSav0—aMV2+ · Biot-TAA (black trace), RuSav1—aMV2+ · Biot-TAA (blue trace), RuSav2—aMV2+ · Biot-TAA 
(green trace) and RuSav3—aMV2+ · Biot-TAA (red trace). 
 
Figure C.24: Temporal evolution of the transient absorption signal at 400 nm of (a) RuSav0—aMV2+, (b) RuSav1—
aMV2+, (c) RuSav2—aMV2+ and (d) RuSav3—aMV2+ with 1 equivalent of Biot-TAA (black traces) and the fitted 
functions (red traces). 
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Figure C.25: Temporal evolution of the transient absorption signal at 400 nm of (a) RuSav0, (b) RuSav1, (c) RuSav2 and 
(d) RuSav3 with 1 equivalent of Biot-TAA and one equivalent of MV2+ in solution (// symbolizes that a compound was 
added in solution). The negative signal at early times is due to bleaching of the sensitizer MLCT absorption band. 
 
Figure C.26: Normalized luminescence decays detected at 630 nm following excitation of RuSav0 (black trace) and 
RuSav0 with 1 eq. Biot-TAA (red trace). 
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Table C.2: Decay time constants (t1, t2, t3) of the photosensitizer luminescence extracted from Figure S23. After addition 
of Biot-TAA an initial rapid decay with a time constant (t1) of ca. 27 ns can be detected. This is attributed to reductive 
quenching and fomration of Biot-TAA+ to Ru(I), as discussed in the main paper. 
 t1 [ns] t2 [ns] t3 [ns] 
RuSav0  444 (24 %) 1207 (74%) 
RuSav0 · Biot-TAA 27 (23%) 314 (22%) 1120 (55%) 
 
The data in Figure C.26 displays that some quenching of the sensitizer's luminescence is caused by 
Biot-TAA in the absence of methyl viologen (initial rapid decay). 
 
 
Figure C.27: Transient absorption spectra of 50 µM of RuSav0—aMV2+(black trace), RuSav1—aMV2+ (blue trace), 
RuSav2—aMV2+ (green trace) and RuSav3—aMV2+ (red trace) in milliQ water at 25 °C, 10 µs after excitation at 450 nm 
in presence of 50 µM TAA-NH2 (// symbolizes that a compound was added in solution). 
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Figure C.28: Transient absorption spectra of 50 µM of RuSav0 (black trace), RuSav1 (blue trace), RuSav2 (green trace) 
and RuSav3 (red trace) in milliQ water at 25 °C, 10 µs after excitation at 450 nm on presence of 50 µM MV2+ (// symbolizes 
that a compound was added in solution). 
 
Figure C.29: Transient absorption spectra of 50 µM RuSav0 (black trace) with 0, 50, 100, 250, 500, 750 µM MV2+ added 
in solution (blue traces) and 50 µM RuSav3 (red trace) with 50 µM MV2+ added in milliQ water at 25 °C, 10 µs after 
excitation at 450 nm (// symbolizes that a compound was added in solution). 
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Figure C.30: Transient absorption spectra of 50 µM of RuSav0 (black trace), RuSav1 (blue trace), RuSav2 (green trace) 
and RuSav3 (red trace) with 50 µM MV2+ and 50 µM Biot-TAA added in milliQ water at 25 °C, 10 µs after excitation at 
450 nm (// symbolizes that a compound was added in solution). 
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D.1 General Methods 
Recombinant streptavidin isoforms were engineered, expressed, purified and quantified as 
previously described.[270,375] Other reagents, substrates and materials were purchased from Sigma, 
Aldrich, TCI and Acros. NMR experiments were performed on a Bruker Avance III NMR 
spectrometer operating at 400 MHz proton frequency and 101 MHz carbon frequency. Chemical 
shifts were referenced to residual Methanol-d6 (3.31 ppm) for 1H spectra or Methanol-d6 (49.00 ppm) 
for 13C spectra. Signals are quoted as s (singlet), d (doublet), t (triplet), q (quintet) and m (multiplet). 
Automated Flash column purification was performed on a Biotage Isolera One with a C18 silica 
column. Mass spectra were acquired on Bruker Esquire 3000 plus and Bruker maxis 4GQTOF EDI 
spectrometers. Hydrogen evolution was measured on a GC (Bruker GC-450 with TCD detector and 
automatic measurement) under a continuous argon flow with a 453 nm LED at 1100 Lux. 
 
 
 
 
 
 
 
 
Supplemental Information Chapter 6 
D 
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D.2 Synthesis 
The compounds 1,[145] 2,[379] 5[373] and [CoBr(appy)-OH]Br[145] were synthesized as previously reported. 
 
 
Scheme D.1: Reaction pathway for the synthesis of [CoBr(appy)-OH]Br and [CoBr(appy)-Biot]Br. 
 
D.2.1 Synthesis of (appy)-N3 
Di-2,2′-bipyridin-6-yl(pyridin-2-yl)methanol (1) (200 mg, 0.48 mmol, 1 eq.) was dissolved in dry 
DMF and NaH (60% in mineral oil; 55.1 mg, 1.44 mmol, 3 eq.) was added. The mixture was left stirring 
for 60 minutes at room temperature. Then 1-azido-3-iodopropane (2) (506 mg, 2.4 mmol, 5 eq.) was 
added and stirring continued for 24 h at room temperature. The reaction mixture was quenched with 
MeOH and HCl (2M) and CH2Cl2 were added and the phases separated. The organic phase was extracted 
with HCl (2M) three times. The combined aqueous phases were then neutralized with NaOH (2M) and 
extracted three times with CH2Cl2. The combined organic phases were dried over MgSO4 and the solvent 
was removed. The crude product was purified by automated reverse column flash chromatography 
(Biotage, 12g C18-silica, H2O/MeOH = 100:0 to 0:100 within 1 h, 12 mL/min). The combined fractions 
containing the product were reduced in vacuo to yield the desired product (appy)-N3 (3) as an off-white 
solid (50.5 mg, 0.10 mmol, 21%). 
 
1H-NMR (400 MHz, Methanol- d4): δ = 8.58 (ddd, J = 4.9, 1.8, 0.9 Hz, 2 H), 8.53-8.50 (m, 1H), 8.24 
(dd, J = 7.8, 1.0 Hz, 2H), 8.13 (dt, J = 8.0, 1.1 Hz, 2H), 7.93 (t, J = 7.9 Hz, 2 H), 7.89-7.70 (m, 6H), 7.41-
7.30 (m, 3H), 3.61 (t, J = 6.0 Hz, 2H), 3.46 (t, J = 6.7 Hz, 2H), 1.89 (p, J = 6.4 Hz, 2H); 13C-NMR (101 
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Mhz, Methanol-d4): δ = 163.01, 162.40, 157.38, 155.43, 149.94, 148.83, 138.53, 138.33, 137.58, 126.30, 
125.56, 125.15, 123.73, 122.64, 120.39, 89.74, 63.16, 49.69, 30.66; HRMS (ESI+) calcd. for [M + H+] 
C29H25N8O 501.2146; found 501.2153. 
 
 
Figure D.1: 1H-NMR spectrum of (appy)-N3 (3) in d4-Methanol. 
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Figure D.2: 13C-NMR spectrum of (appy)-N3 (3) in d4-Methanol. 
 
D.2.2 Synthesis of (appy)-NH2 
The azide (appy)-N3 (3) (30 mg, 0.06 mmol) was dissolved in dry MeOH under N2. Then Pd/C 
(5 mg, 10% Pd) was added and a balloon filled with H2 was attached. The solution was stirred vigorously 
for 24 h at room temperature. The mixture was filtered over Celite and the plug was washed with MeOH. 
The solvent was removed in vacuo to yield the reduced product (appy)-NH2 (4) as an off-white solid 
(quantitative).  
 
1H-NMR (400 MHz, Methanol-d4): δ = 8.62 (ddd, J = 4.9, 1.8, 0.9 Hz, 2 H), 8.56 (ddd, J = 5.0, 1.7, 0.9 
Hz, 1 H), 8.27 (dd, J = 7.9, 1.0 Hz, 2H), 8.04-7.94 (m, 5H), 7.90 (ddd, J = 8.1, 7.3, 1.7 Hz, 1H), 7.80 (td, 
J = 7.7, 1.0 Hz, 2H), 7.69 (dd, J = 7.9, 1.0 Hz, 2H), 7.45-7.34 (m, 3H), 3.52 (t, J = 6.0 Hz, 2H), 3.28 (t, J = 
6.7 Hz, 2H), 2.04 (p, J = 5.6 Hz, 2H); 13C NMR (101 MHz, Methanol-d4): δ = 162.07, 161.64. 157.08, 
155.81, 150.20, 148.03, 138.96, 138.61, 137.60, 128.80, 125.33, 124.97, 124.25, 122.52, 121.04, 90.44, 
66.19, 40.81, 28.07; HRMS (ESI+) calcd. for [M + H+] C29H27N6O 475.2241; found 475.2246. 
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Figure D.3: 1H-NMR spectrum of (appy)-NH2 (4) in d4-Methanol. 
 
 
Figure D.4: 13C-NMR spectrum of (appy)-NH2 (4) in d4-Methanol. 
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D.2.3 Synthesis of (appy)-Biot 
The amine (appy)-NH2 (4) (20 mg, 0.04 mmol, 1 eq.) was dissolved in dry DMF (1 ml) and it 
was cooled to 0°C. Then Biotin-pentafluorophenylester (5) (18.2 mg, 0.044 mmol, 1.05 eq.) and 
trimethylamine (4.45 mg, 6.1 µl, 0.044 mmol, 1.05 eq.) were added. The solution was allowed to come to 
room temperature und left stirring for 15 h. Then HCl (2M) and CH2Cl2 were added and the phases 
separated. The organic phase was extracted with HCl (2M) three times. The combined aqueous phases 
were then neutralized with NaOH (2M) and extracted three times with CH2Cl2. The combined organic 
phases were dried over MgSO4 and the solvent was removed. The crude product was purified by 
automated reverse column flash chromatography (Biotage, 12g C18-silica, H2O/MeOH = 100:0 to 0:100 
within 1 h, 12 mL/min). The combined fractions containing the product were reduced in vacuo to yield 
the desired product (appy)-Biot (6) as an off-white solid (17.7 mg, 0.025 mmol, 63%). 
13C-NMR (101 MHz, d4-Methanol): δ = 175.70, 166.07, 162.96, 162.48, 157.34, 155.48, 150.00, 148.81, 
138.56, 138.40, 137.53, 126.59, 125.56, 125.19, 123.79, 122.64, 120.47, 89.80, 64.37, 63.31, 61.57, 56.90, 
41.02, 38.19, 36.99, 30.74, 29.76, 29.41, 26.85; HRMS (ESI+) calcd. for [M + H+] C39H41N8O3S 
701.3017; found 701.3007. 
 
 
Figure D.5: 1H-NMR spectrum of (appy)-Biot (5) in d4-Methanol. 
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Figure D.6: 1H-NMR spectrum of (appy)-Biot (5) in d4-Methanol. 
 
D.2.4 Synthesis of [CoBr(appy)-Biot]Br 
The ligand (appy)-Biot (5) (10 mg, 0.014 mmol, 1 eq.) was dissolved in dry MeOH (2.0 ml). 
Then CoBr2 · 6H2O (4.66 mg, 0.014 mmol, 1 eq.) was added and left stirring for 3 h at room 
temperature. Afterwards, excess of Et2O was added to precipitate the product. The solid was filtered 
off, washed 3 times with Et2O, recrystallized in MeOH and dried in vacuo to give [CoBr(appy)-OH]Br 
as light brown solid (10.6 mg, 0.011 mmol, 77%).  
HRMS (ESI+) calcd. for [M+] C39H39CoN8O3S 758.2192; found 758.2188. 
 
D.3 Biotin-binding activity determination[237,242] 
The Sav mutants (76.8 nmol) were dissolved in NaH2PO4 buffer (2.4 ml, 20 mM, pH 7.0). The 
solutions were treated with a 2-(4-hydroxyphenylazo)benzoicacid (HABA) solution (300 µl, 9.6 
mM) in NaH2PO4 buffer (20 mM, pH 7.0), filled into a cuvette and left standing for 5 minutes. A 
blank of the buffer was measured at 506 nm in a Varian50 Scan UV-Vis spectrophotometer. The 
resulting sample was analyzed and aliquots (5.0 µl) of a biotin (or [CoBr(appy)-Biot]Br) solution 
(0.96 mM) in H2O were added after each spectroscopic determination. The data points were plotted 
  128 
with Origin Pro 9.0.0 to determine the number of biotin-binding sites and the stoichiometry for the 
Sav embedded triads. 
  
Figure D.7: HABA displacement titrations of [CoBr(appy)-Biot]Br (black symbols) and biotin (red symbols) with 
SavWT (left) and S112K (right). The biotinylated cofactors show a similar binding affinity as the native biotin. 
 
D.4 TON and rates 
 
Figure D.8: Comparison of rates (dotted lines, left scale) and the TON of produced H2 per WRC (solid lines, right scale) 
with 5 µM WRC, 1 M ascorbate buffer (pH 4) and 100 µM Ru(bpy)32+ in each experiment and 10 µM free biotin binding 
sites, when protein was present. [CoBr(appy)-OH]Br (black trace), [CoBr(appy)-Biot]Br (blue trace) with additional 
S112K (red trace). 
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Figure D.9: Comparison of rates (dotted lines, left scale) and the TON of produced H2 per WRC (solid lines, right scale) 
with 5 µM WRC, 1 M AcOH, 0.1 M AscOH (pH 5.7) and 100 µM Ru(bpy)32+ in each experiment and 10 µM free biotin 
binding sites, when protein was present. [CoBr(appy)-OH]Br (black trace), [CoBr(appy)-Biot]Br (blue trace) with 
additional S112K (red trace). 
 
 
Figure D.10: Comparison of rates (dotted lines, left scale) and the TON of produced H2 per WRC (solid lines, right scale) 
with 5 µM WRC, 1 M NaHPO4, 0.1 M AscOH (pH 6) and 100 µM Ru(bpy)32+ in each experiment and 10 µM free biotin 
binding sites, when protein was present. [CoBr(appy)-OH]Br (black trace), [CoBr(appy)-Biot]Br (blue trace) with 
additional S112K (red trace). 
 
 
 
0 2 4 6
0
200
400
600
800
1000
1200
1400
 
Time [h]
 [CoBr(appy)-OH]Br
 [CoBr(appy)-Biot]Br
 [CoBr(appy)-Biot]Br + S112K
0.0
2.5
5.0
7.5
10.0
12.5
15.0
 TO
N
W
R
C  [H
2 /W
RC
]Ra
te
 [n
m
ol
 H
2/s
]
0 5 10 15
0
200
400
600
800
1000
1200
1400
 
Time [h]
 [CoBr(appy)-OH]Br
 [CoBr(appy)-Biot]Br
 [CoBr(appy)-Biot]Br + S112K
0
1
2
3
4
5
R
at
e 
[n
m
ol
 H
2/s
]  TO
N
W
R
C  [H
2 /W
R
C
]
  130 
 
Figure D.11: Comparison of rates (dotted lines, left scale) and the TON of produced H2 per WRC (solid lines, right scale) 
with 5 µM WRC, 1 M NaHPO4, 0.1 M AscOH (pH 6.2) and 100 µM Ru(bpy)32+ in each experiment and 10 µM free biotin 
binding sites, when protein was present. [CoBr(appy)-OH]Br (black trace), [CoBr(appy)-Biot]Br (blue trace) with 
additional S112K (red trace). 
 
 
Figure D.12: Comparison of rates (dotted lines, left scale) and the TON of produced H2 per WRC (solid lines, right scale) 
with 5 µM WRC, 1 M NaHPO4, 0.1 M AscOH (pH 6.5) and 100 µM Ru(bpy)32+ in each experiment and 10 µM free biotin 
binding sites, when protein was present. [CoBr(appy)-OH]Br (black trace), [CoBr(appy)-Biot]Br (blue trace) with 
additional S112K (red trace). 
 
Figure D.13: Comparison of rates (dotted lines, left scale) and the TON of produced H2 per WRC (solid lines, right scale) 
with 5 µM WRC, 1 M NaHPO4, 0.1 M AscOH (pH 7) and 100 µM Ru(bpy)32+ in each experiment and 10 µM free biotin 
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binding sites, when protein was present. [CoBr(appy)-OH]Br (black trace), [CoBr(appy)-Biot]Br (blue trace) with 
additional S112K (red trace). 
 
 
Figure S14: Comparison of rates (dotted lines, left scale) and the TON of produced H2 per WRC (solid lines, right scale) 
with 5 µM WRC, 1 M NaHPO4, 0.1 M AscOH (pH 7.5) and 100 µM Ru(bpy)32+ in each experiment and 10 µM free biotin 
binding sites, when protein was present. [CoBr(appy)-OH]Br (black trace), [CoBr(appy)-Biot]Br (blue trace) with 
additional S112K (red trace). 
 
Table D.1: Maximal rates measured, errors and the times when the maximal rates were achieved. 
pH [CoBr(appy)-OH] [CoBr(appy)-Biot] 
[CoBr(appy)-Biot] + 
SavWT 
CoBr(appy)-Biot] + 
K121W 
CoBr(appy)-Biot] + 
S112K 
 
Max. rate 
[nmol 
H2/WRC] 
t [min] 
Max. rate 
[nmol 
H2/WRC] 
t 
[min] 
Max. rate 
[nmol 
H2/WRC] 
t [min] 
Max. rate 
[nmol 
H2/WRC] 
t [min] 
Max. rate 
[nmol 
H2/WRC] 
t [min] 
4 8.6 ± 0.3 29.4 6.1 ± 0.4 34.4     7.4 ± 0.4 29.4 
5 12.3 ± 0.7 39.7 8.6 ± 0.6 44.8 6.7 ± 0.2 34.6 4.2 ± 0.3 22.8 11.1 ± 0.6 40.8 
5.7 8.0 ± 0.3 42.0 8.4 ± 0.5 37.0     10.8 ± 0.6 32.0 
6 2.2 ± 0.1 154.0 3.3 ± 0.2 146.0     4.2 ± 0.2 89.7 
6.2 2.0 ± 0.1 161.0 2.9 ± 0.2 151.0     4.1 ± 0.2 85.0 
6.5 1.29 ± 0.04 246.0 2.1 ± 0.1 216.0     2.8 ± 0.2 135.0 
7 0.98 ± 0.03 495.0 1.4 ± 0.1 513.0     1.6 ± 0.1 327.0 
7.5 0.98 ± 0.03 1020.0 1.3 ± 0.1 645.0     1.4 ± 0.1 487.0 
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Table D.2: Table of maximal turnover numbers and its errors measured when the experiment was aborted (t in min).  
pH t [min] 
[CoBr(appy)-
OH] 
[CoBr(appy)-
Biot] 
[CoBr(appy)-Biot] 
+ SavWT 
CoBr(appy)-Biot] + 
K121W 
CoBr(appy)-Biot] 
+ S112K 
4 466 556 ± 21 458 ± 32   455 ± 27 
5 385 1121 ± 61 1055 ± 68 818 ± 28 396 ± 26 1070 ± 58 
5.7 377 1108 ± 38 1141 ± 74   1222 ± 66 
6 1034 899 ± 32 1227 ± 80   1320 ±72 
6.2 1324 1088 ± 39 1504 ± 98   1546 ± 84 
6.5 1450 1117 ± 40 1668 ± 109   1722 ± 94 
7 1332 1119 ± 40 1569 ± 103   1839 ± 100 
7.5 4690 3364 ± 122 3742 ± 248   3294 ± 187 
 
 
Figure D.15: Comparison of the produced amounts of H2 in control experiments, with 1 M ascorbate buffer (pH 5) 
and 100 µM Ru(bpy)32+ in each experiment and 5 µM Co and 10 µM free biotin binding sites, when applicable. 
Ru(bpy)32+ only (black trace), additional S112K (green trace), CoBr2 (orange trace), CoBr2 and S112K (blue trace) 
and [CoBr(appy)-Biot]Br within S112K (red trace). No significant amounts of hydrogen were produced, when no 
catalyst was present. 
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D.5 Crystal Structure Data 
 
 
Figure D.16: Crystal structure of complex [CoBr(appy)-Biot] × Sav-K121A. The protein is displayed as cartoon 
and the cofactor as stick model. The orange sphere indicates a cobalt and the magenta stick a water molecule. 
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